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Characterization of the Agrobacterium tumefaciens VirB2 pilin
of the VirB/D4 Type IV Secretion System
Publication No.___________
Jennifer Evangeline Kerr
Supervisory Professor: Peter J. Christie, Ph.D.
The Agrobacterium tumefaciens VirB/D4 type IV secretion system (T4SS) delivers
oncogenic T-DNA and effector proteins to susceptible plant cells. This leads to the
formation of tumors termed Crown Galls. The VirB/D4 T4SS is comprised of 12 subunits
(VirB1 to VirB11 and VirD4), which assemble to form two structures, a secretion channel
spanning the cell envelope and a T-pilus extending from the cell surface. In A. tumefaciens,
the VirB2 pilin subunit is required for assembly of the secretion channel and is the main
subunit of the T-pilus. The focus of this thesis is to define key reactions associated with the
T4SS biogenesis pathway involving the VirB2 pilin. Topology studies demonstrated that
VirB2 integrates into the inner membrane with two transmembrane regions, a small
cytoplasmic loop, and a long periplasmic loop comprised of covalently linked N and C
termini. VirB2 was shown by the substituted cysteine accessibility method (SCAM) to adopt
distinct structural states when integrated into the inner membrane and when assembled as
a component of the secretion channel and the T-pilus.

The VirB4 and VirB11 ATPases

were shown by SCAM to modulate the structural state of membrane-integrated VirB2 pilin,
and evidence was also obtained that VirB4 mediates extraction of pilin from the membrane.
A model that VirB4 functions as a pilin dislocase by an energy-dependent mechanism was
further supported by coimmunoprecipitation and osmotic shock studies. Mutational studies
identified two regions of VirB10, an N-terminal transmembrane domain and an outer
membrane-associated domain termed the antennae projection, that contribute selectively to
T-pilus biogenesis.

Lastly, characterization of a VirB10 mutant that confers a ‘leaky’

channel phenotype further highlighted the role of VirB10 in gating substrate translocation
across the outer membrane as well as T-pilus biogenesis. Results of my studies support a
working model in which the VirB4 ATPase catalyzes dislocation of membrane-integrated
pilin, and distinct domains of VirB10 coordinate pilin incorporation into the secretion channel
and the extracellular T-pilus.
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Chapter 1: Introduction

NOTE: Crystal structure images were modeled in PyMOL. An educational-use program
copy of PyMOL was obtained from http://pymol.org/ep, which states that images may be
used for thesis/dissertation projects. All structural coordinates were obtained from the
RCSB protein data base http://www.rcsb.org/pdb and individual identification numbers and
specific references are included in the figure legends. Figure 1.1 was modified from figure 1
in a previously published review article: “The versatile bacterial type IV secretion systems.”
Nature Reviews Microbiology 1, 137-14; November 2003, (doi:10.1038/nrmicro753). I have
been given permission by the publisher of Nature Reviews Microbiology, Nature Publishing
Group, to reproduce this figure in print or electronically for the purposes of my dissertation
(License Number 2544420868323). Figure 1.4 was modified from Figure 3 in “The T-pilus
of

Agrobacterium

tumefaciens.”

Trends

Microbiol.

8, 361-69.

(doi:10.1016/S0966-

842X(00)01802-3). I have been given permission by the publisher of Trends in
Microbiology, Elsevier, to reproduce this figure in print or electronically for the purposes of
my dissertation (License Number 2551440934372).
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I)

Type IV Secretion Systems
Bacterial Type IV secretion systems (T4SSs) represent a functionally diverse group

of transporters dedicated to the movement of DNA or protein substrates across the cell
envelope (1-3). They are linked to many important processes, such as the spread of
antibiotic resistance (4-6), genomic plasticity (7), bacterial colonization, and the introduction
of virulence factors into eukaryotic host cells (1, 8-14). T4SSs are widely distributed among
both Gram-negative and Gram-positive bacteria (1, 4, 15), and they play a key role in the
virulence of many bacterial pathogens (16-22). These systems stimulate changes in basic
host cellular processes that aid in the establishment of pathogenic or symbiotic
relationships with the host (1, 16, 23, 24). All T4SSs identified assemble as multi-subunit
machines that form a secretion channel spanning the cell envelope, and many T4SSs also
encode a pilus or other surface protein(s) that mediates direct contact with target cells (15,
16, 25-28). These systems have been grouped into three different ‘types’ based on
function: 1) conjugation machines, systems that translocate DNA to recipient cells through
direct cell-cell contact, 2) DNA uptake/release machines that translocate DNA to or from the
milieu, and 3) effector translocation machines, which transport proteins and sometimes
DNA to eukaryotic recipient cells (Fig. 1.1) (2, 15).

II)

Agrobacterium tumefaciens Type IV Secretion System
The prototypical T4SS, the Agrobacterium tumefaciens VirB/D4 system, serves as

an excellent model for defining substrates and substrate translocation signals, assembly
pathways and architectures, and the dynamics of substrate movement through the T4SSs.
The A. tumefaciens VirB/D4 T4SS is comprised of a secretion channel and an extracellular
pilus called the T-pilus (2, 3, 29, 30) (Fig. 1.2). The secretion channel mediates the transfer
of effector proteins and DNA across the cell envelope. The T-pilus functions mainly or
exclusively as an attachment organelle to enable formation of productive contacts between
A. tumefaciens and target cells. Though not required for substrate translocation, the T-pilus
increases substrate transfer efficiencies (31, 32).
III)

Infection Process
As with many bacterial pathogens, A. tumefaciens infects only at wound sites in a

cell-cell contact dependent fashion (33, 34). Infection is initiated when bacteria sense an
array of signals, including various plant cell wall precursors and acidic pH, that are present
at a plant wound site (35). Signal perception is mediated by the VirA/VirG signal

2

Figure 1.1 Schematic of the role of type IV secretion systems in bacteria
Three groups of type IV secretion systems depicted: 1) Conjugation, deliver plasmids or
integrative and conjugative elements (ICEs) from donor cells to recipient cells 2) DNA
uptake/release, mediate exchange of DNA with the extracellular milieu and, 3) Effector
translocators, deliver DNA and/or protein substrates to eukaryotic cells and are directly
involved in virulence (See (1, 16, 30, 36, 37)). This figure was modified from Figure 1 in
“The versatile bacterial type IV secretion systems.” Nature Reviews Microbiology 1, 137-14;
November 2003, (doi:10.1038/nrmicro753).
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Figure 1.2 Schematic of the localization of the Agrobacterium tumefaciens VirB/D4
type IV secretion components and the T-DNA secretion pathway
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown
according to their proposed localization and interactions. Black arrows indicate the path of
the translocating T-DNA. The T-DNA interacts directly with VirD4, VirB11, VirB6, VirB8, and
finally VirB2-VirB9. P: periplasm; IM: inner membrane; OM; outer membrane.
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transduction system (38). VirA detects signals released from wounded plant tissues and
VirG activates transcription of the vir operon. The VirB/D4 system delivers an oncogenic
nucleoprotein complex into plant cells, resulting in the formation of tumors called Crown
Galls which can devastate agriculturally important crop species (1, 5, 39).
The majority of genes required for tumorigenesis are found within pathogenic A.
tumefaciens strains on large (~180kb) extrachromosomal elements called Tumor-inducing
(Ti) plasmids (40, 41).

A. tumefaciens can conjugatively transfer the Ti-plasmid to

Agrobacterium and Rhizobium recipients, and upon transfer these strains can now infect
plants through T-DNA transmission (14, 41). The Ti plasmid harbors the T-DNA and the
virulence (vir) genes involved in T-DNA transfer to susceptible plant cells. The T-DNA
carried on a separate region of the Ti-plasmid, is typically 10-30 kb in length and delimited
by the left and right border repeat sequences. None of the T-DNA genes are required for its
secretion, and therefore, all DNA between the border repeats can be excised and
substituted with DNA of interest for delivery to plant or other eukaryotic target cells (42-44).
The VirB proteins are encoded by the virB1 through virB11 genes expressed from a single
promoter (1, 39). VirB1 - VirB11 are mating pair formation proteins (mpf) that form the
translocation channel and the T-pilus (5). The virD operon encodes the relaxase VirD2
substrate and ancillary protein VirD1 required for excision of the T-DNA and its export from
the bacterium, as well as the coupling protein VirD4 that functions as a receptor for the TDNA transfer intermediate and several independently translocated proteins (45, 46).
Following signal perception and vir gene induction, T-DNA is processed and
exported across the A. tumefaciens cell envelope via the T4SS encoded by the virB operon.
It then moves through the plant cell to the nucleus where it integrates into the plant genomic
DNA. The virE operon encodes the single-stranded DNA-binding protein (SSB) VirE2 that
interacts with the T-DNA, forming the T-complex.

VirE2 protects the T-DNA from

cytoplasmic nucleases in the plant cell and mediates delivery of the T-DNA to the plant
nuclear pore with the help of VirE3 (47-52). VirF, another translocated effector protein,
appears to be involved in targeted proteolysis of VirE2 after its arrival in the host nucleus
(53). Once integrated in the plant genome, the T-DNA genes are expressed and the protein
products catalyze synthesis of novel amino acids, called opines. Opines are released from
the plant cell and can be taken up and catabolized for use as carbon and energy sources
by the infecting bacteria. The T-DNA genes also code for proteins that disrupt biosynthetic
pathways of the plant hormones auxin and cytokinin. The resulting hormonal imbalance
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leads to uncontrolled cell proliferation and formation of the unorganized tumors, termed
‘Crown Galls’ (40).

IV)

Substrates Transferred by the Secretion Channel
A. tumefaciens uses the VirB/VirD4 T4SS to translocate the T-DNA as a single-

stranded DNA particle bound covalently at its 5’ end to the VirD2 relaxase. A. tumefaciens
also uses this T4SS to translocate protein substrates only. These include the VirE2 SSB,
VirE3, and VirF (54). The first evidence for protein translocation independently of T-DNA
transfer derives from mixed infection experiments in which it was shown that the coinfection of plants with two avirulent A. tumefaciens strains, one deleted of T-DNA but with
an intact vir region, and a second mutated for virE2 or virF, resulted in tumorigenesis (55,
56).

More recent studies showed that protein substrates fused to reporter proteins such

as the Cre recombinase (57) can mobilize the transfer of the reporter protein to target cells.
Most T4SSs recognize substrates by detecting a signal sequence located within the protein
components, e.g. relaxase or effector proteins. These ‘secretion’ signals are located close
to the C termini and mainly consist of hydrophobic or positively-charged clusters of amino
acids (15).
The T-DNA substrate was shown to form close sequential contacts with channel
subunits along the secretion pathway (Fig, 1.2) (58). VirD4, termed a coupling protein or
substrate receptor, initiates the transfer process by recruiting the T-DNA substrate to the
T4SS. Additional studies have also shown that VirD4 recruits protein substrates such as
VirE2 to the secretion channel (45, 59). The DNA substrate next makes contacts with
ATPase VirB11 (45), and VirB11 in turn transfers the substrate to the inner membraneassociated subunits VirB6 and VirB8. Finally, the T-DNA forms close contacts with the
outer-membrane-associated VirB9 and the VirB2 pilin. On the basis of these demonstrated
T-DNA – T4SS subunit close contacts, it was proposed that the VirB/VirD4 secretion
channel that spans the cell envelope is composed minimally of VirD4, VirB11, VirB6, VirB8,
VirB2, and VirB9. Other subunits are required for substrate transfer, and it is thought that
some of these might form a scaffold for the assembly of the transenvelope channel. One of
these proposed scaffold proteins is VirB10, and recent findings suggest that VirB10 spans
the entire Agrobacterium cell envelope and participates in energizing substrate transfer
through the distal portion of the transfer channel (58).
The VirB/D4 translocation system also mediates the conjugal transfer of RSF1010,
a non-self-transmissible IncQ plasmid, into plant cells as well as between Agrobacterial
8

cells (60, 61). This transfer requires the plasmid’s origin of transfer (oriT) and the RSF1010encoded MobA nicking enzyme, suggesting that the VirB complex recognizes the IncQ
transfer intermediate, capped at its 5’ end with MobA. The RSF1010 transfer intermediate
was shown to follow the same substrate transfer pathway as the T-DNA, and it also was
shown to competitively interfere with T-DNA and VirE2 substrate binding to the VirD4
receptor (62). Taken together, these observations support the idea that the VirB/D4 T4SS
is a multifunctional translocation apparatus that exports diverse substrates through
recognition of amino acid sequence or structural motifs. The VirD4 substrate receptor and
all VirB proteins except for the VirB1 transglycosylase are required for transfer of the VirD2T-strand and MobA-RSF1010 transfer intermediates, VirE2, and VirF (61, 63, 64).
V)

General Architectural Features of VirB/D4 T4SS
The T4SSs of Gram-negative bacteria span the entire cell envelope and present

substrates with a conduit to transit through the periplasm and bacterial membranes (2, 3,
15, 30). Based on recent structural, functional, and biochemical studies, these proteins can
be grouped by function/location (Fig. 1.2, see below for more detailed introduction). There
are three cytoplasmic-associated ATPases, VirB4, VirB11, and VirD4, which provide energy
for substrate transfer and machine assembly (30, 45). VirB6 through VirB10 and possibly
VirB3 form the bulk of the channel scaffold that spans from the inner membrane to the outer
membrane (2, 58, 65-67). VirB3, VirB6, and VirB8 all reside at the inner membrane and
form portions of the base of the channel (58, 65, 66). VirB7, VirB9, and VirB10 interact to
form a multi-subunit ‘core’ complex that spans the entire cell envelope (67, 68). VirB2 and
VirB5 form part of the secretion channel but also polymerize to form the extracellular T-pilus
(25, 69).

VI)

Structure-Function Analysis of Type IV Secretion System Core Components
VirB7, VirB8, VirB9, and VirB10 are conserved among most T4SS of Gram bacteria

(39, 70) and are postulated to comprise the T4SS ‘core’ subunits (67, 68, 71-73). VirB7 is a
small lipoprotein that stabilizes VirB9, partly through a disulfide crosslink (74, 75). VirB9
subunits are hydrophilic but associated with the outer membrane. VirB8 and VirB10 are
bitopic membrane proteins that both posses a globular periplasmic domain. The periplasmic
domains of the A. tumefaciens and Brucella suis VirB8 subunits were solved by X-ray
crystallography (76). VirB8 has been shown to be important for spatial positioning of the
VirB proteins and may, therefore, function as a nucleation center for the T4SS (29, 77).
9

VirB10 subunits have a short N-terminal domain, a transmembrane region, a proline-rich
region, and a C-terminal β-barrel domain (73, 78, 79).

VirB10 is an energy

sensor/transducer that undergoes a conformational change in response to ATP hydrolysis
from VirB11 and VirD4 to activate substrate transfer through the distal portion of the
secretion channel (58).
Recent studies have shown for the related pKM101 T4SS that VirB7-like TraN,
VirB9-like TraO, and VirB10-like TraF assemble as a stable ‘core’ complex (67, 68). This
core complex was visualized as a large (185 Å wide and long) ring-shaped channel by
cryoelectron microscopy (CryoEM) and X-ray crystallography. The complex, composed of
14 copies of each subunit, consists of two stacked layers (I- and O-layers) linked by a thin
density stretch. The I- and O-layers are double-walled, ring structures that create a hollow
chamber that is thought to span the cell envelope. The I-layer is anchored at the inner
membrane while the O-layer is stacked on top and inserted into the outer membrane. The Ilayer is composed of the N-terminal domains of TraO and TraF; the O-layer is formed by
TraN and C-terminal domains of TraO and TraF.
Outer Membrane Core Complex Structure
The structure of the distal portion of the core complex, presumptively located near
the outer membrane, was resolved by X-ray crystallography (68). This complex
corresponds to the O-layer visualized by CryoEM and contains 14 copies of the C-terminal
domains of TraO and TraF and the full-length TraN (Fig. 1.3A and B). Alpha helical
projections extending from the top the TraF β-barrel create a halo which forms the outer
membrane ‘pore’. The remainder of the C-terminal domain of TraF shapes the inner
chamber of the O-layer surrounded by the TraN-TraO complex (Fig. 1.3 A and B). The Cterminal domains of TraO and TraF interact directly, while full-length TraN interacts with the
C-terminal domain of TraO but not with TraF [Fig. 1.3A and refer to (68)].

Given the

sequence conservation between these pKM101 Tra proteins and the VirB as well as other
T4SS core subunits, the Tra core structure is postulated to represent a structural paradigm
for core complexes of all Gram-negative bacterial T4SSs. Notably, no other proteins were
found associated with this outer membrane core complex (67, 68) and the T-DNA substrate
was never shown to form a close contact with VirB10 (58). VirB2, which is required for
substrate transfer and T-pilus formation, forms the distal portion of the secretion channel
and may, therefore, form a secretion conduit inside the VirB10 pore. The core complex
may in addition serve as a base for assembly of the extracellular T-pilus; however,
10

Figure 1.3 Structure of the ‘core’ type IV secretion system
A) Crystal structure of the outer membrane complex, comprising the O-layer. TraN, TraO,
TraF are colored blue, yellow, and red respectively. VirB7, VirB9, VirB10 homologues
encoded by pKM101. VirB7, VirB9CTD, VirB10CTD heterotrimer, side view with periplasmic
side facing downwards B) Crystal structure of complete pKM101 outer membrane core
complex Top: Tilt-view from outer-membrane Bottom: Side view with periplasmic side
facing downwards. Modeled with coordinates from pKM101 core outer membrane complex
X-ray structure (DOI:10.2210/pdb3jqo/pdb) (68) using the PyMOL (http://pymol.org/) to
construct the figure.
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at this point,no studies have outlined the functional relationship between the VirB2 pilin and
core component VirB10.

Structure of the Inner Membrane Complex
The I-layer was resolved at ~15 Å by cryoelectron microscopy (67). The I-layer is
composed of the N-terminal domains of TraO and TraF. TraF inserts into the inner
membrane forming a portion of the base of the core structure (67, 68). In the A.
tumefaciens system, we propose that the VirB7/VirB9/VirB10 complex represents a scaffold
for the T4SS, and that the other channel subunits assemble within the core chamber to
form the translocation channel.

Correspondingly, the ring formed by 14 copies of the

VirB10 transmembrane (TM) sequence would encircle the translocase, comprised of
polytopic VirB6, bitopic protein VirB8 and, possibly, other subunits (3, 80, 81). VirB6 and
VirB8 form close contacts with the T-DNA (58) (3, 80, 81). VirB6 has 5 transmembrane
domains and a large periplasmic region that has been shown to be important for making
T4SS interactions (65, 82). VirB8, as mentioned above, may play a key role in localization
of the T4SSs (29, 77). VirB9 likely forms portion of the translocation channel extending
through the periplasm to the outer membrane. Finally, VirB2 would assemble within the
core chamber to comprise the distal-most portion of the transfer channel (Fig. 1.2) (58).

Inner Membrane-Associated ATPases
Most T4SS have two to three dedicated ATPases that supply energy needed for
assembly or function of the translocation channel and T-pilus (15). In A. tumefaciens, all
three ATPases (VirB4, VirB11, and VirD4) are required for substrate transfer, whereas
VirB4 and VirB11 but not VirD4 are required for T-pilus biogenesis. These ATPases interact
with each other, likely forming an ATPase complex at the cytoplasmic entrance to the T4SS
channel (45). This ATPase complex probably interacts with VirB6, VirB8 and/or VirB10 at
the inner membrane in order to energize the T4SS (83). Yet, the exact architecture of this
complex and the specific role each ATPase plays during transfer and machine assembly of
the secretion channel and the T-pilus remains unknown.
VirB11 and its homologs are widely distributed among Gram-negative and Grampositive bacteria and several species of Archaea (15). These ATPase are tightly-associated
with the inner membrane but do not possess any known transmembrane regions. VirB11
self-associates (84), and structural studies of VirB homologues e.g. TrbBRP4, TrwCR388,
HP0525Cag, and Brucella suis VirB11 have supplied evidence that this family of ATPases
13

assemble as double-stacked, homohexameric rings (84, 85, 86). The crystal structure of
ADP-bound HP0525 from H. pylori showed that the N termini and the C termini form two
globular domains that are separated by the NTP-binding domain (85). VirB11-like subunits
are expected to share structural features, although a comparison of H. pylori HP0525 and
B. suis VirB11 identified structural differences between inter-domain contacts within the
respective homohexamers (86).

VirB11 and homologs contain Walker nucleoside

triphospate (NTP) binding regions; where examined, mutation of the Walker A motif
(GxxGxGKT/S) abolishes both channel activity and pilus biogenesis (87-92). Studies from
our lab also identified mutations that selectively abolish T-pilus production without affecting
substrate transfer (87); how VirB11 regulates biogenesis of either terminal organelle has
not been established.
VirD4 is a member of the family of ATPases termed coupling proteins or substrate
receptors. Coupling proteins are present in all characterized conjugation systems to date
(15). These subunits recruit substrates by serving as substrate receptors at the base of the
T4SSs, thus linking the substrate processing and translocation reactions. The VirD4
coupling protein and its homologs TraDF, TrwBR388, and TraGRP4 have been extensively
characterized through biochemical and structural studies (93-96). They contain three
domains: an NTP-binding region, an N-terminal transmembrane region, and an all-αdomain. A crystal structure was obtained for the coupling protein TrwBR388 deleted of its
transmembrane region (97).

This structure presents as a homohexameric ring, and

modeling of the N-terminal transmembrane stem yielded an overall F1F0 ATPase-like ballstem structure (97, 98). Mutagenesis of the conserved Walker NTP-binding motifs in VirD4
and homologs abolishes protein function (99-101). Several coupling proteins have been
shown to bind single and double stranded DNA (93, 94, 102). Biochemical studies have
also supplied evidence that coupling proteins self-associate and also interact with other
T4SS components, e.g. VirD2, VirB4, VirB10, and VirB11 (45, 83, 103, 104).
VirB4-like ATPases are ubiquitous across all T4SSs described (15). Studies from
our laboratory have demonstrated that the VirB4 protein is a membrane-associated ATPase
containing two periplasmically exposed domains (105), however, soluble versions of VirB4
homologs have also been identified in other systems. VirB4 self associates, and also
interacts with VirD4, VirB11, VirB8, VirB10, and VirB11 (45, 83, 106, 107). Homology
between the C terminus and the coupling proteins TrwBR388 suggests that C-terminal
domain of VirB4 would form a homohexamer (108). Yet, studies have identified both
dimeric and hexameric forms of VirB4 homologs (78, 106, 108-110). Phenotypic studies
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established the importance of the Walker NTP-binding motif and, by extension, VirB4 NTPbinding and/or hydrolysis activities, for substrate translocation and pilus biogenesis (87,
104, 105, 111, 112). In addition, alleles encoding a VirB4 NTP-binding mutant exhibit
transdominant effects over the wild-type virB4 gene, suggesting that VirB4 functions as a
homo- or heteromultimer (105). Biochemical studies showed that a purified VirB4 homolog
binds and hydrolyses ATP (113). Although the specific function of these activities is not
known, the transmembrane topology of VirB4 and its likely interactions with components
localized at the inner membrane, suggest that VirB4 can energize ATP-induced
conformational changes necessary for biogenesis of the T4SS.

VII)

VirB2 Pilin and the T-Pilus Biogenesis Pathway
The VirB proteins direct assembly of the extracellular T-pilus (25). The T-pilus is

composed of VirB2 pilin and the VirB5 minor subunit (25, 31, 114). VirB2 homologs or
orthologs, with low levels of similarity yet retaining key residues, are present in several
other T4SSs (78). The VirB2-like proteins are typically small and hydrophobic, and they
also contain a cleavable signal sequence (Fig. 1.4) (115, 116). Several novel processing
reactions are known to be associated with pilin maturation (115). The VirB2 pro-pilin is 121
amino acids, the first 47 comprising an unusually long signal sequence. After cleavage, the
74-residue peptide is further processed by joining of the N- and C-termini, forming a cyclic
peptide.

The mature pilin is composed of two hydrophobic domains and two short

hydrophilic domains (104, 117). When synthesized in E. coli, the signal sequence of VirB2
is cleaved but the mature protein is not cyclized (118). In A. tumefaciens, the cyclized
mature pilin is presumably shunted through the core channel complex and serves as the
building block for assembly of a functional secretion channel and the extracellular T-pilus
(58) (Fig. 1.5).
The T-pilus has been shown to localize at the A. tumefaciens cell poles (104, 119).
Little is known about the function of the T-pilus. There is some evidence, using VirB2 in
yeast two hybrid screening methods aimed at identifying plant host receptors, that T-pili are
involved with sensing of the host cell surface (120). No structural information is available for
VirB2 or the T-pilus; however, a structure was solved for a VirB5 homolog, TraCpKM101.
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Figure 1.4 Sequence alignment of VirB2 pro-pilin homologues
The homologs of A. tumefaciens VirB2 pro-pilins (At VirB2) were aligned using CLUSTAL
W program and edited manually. The homologous proteins shown here are LvhB2 in
Legionella pneumophila (Lp LvhB2), VirB2 in Brucella suis (Bs VirB2), PtlA in Bordetella
pertussis (Bp PtlA), VirB2 in Bartonella henselae (Bh VirB2), TraM of IncN plasmid
pKM101, TrwM of IncW plasmid R388, TrbC of IncP plasmid RP4, and TraA of IncF
plasmid F. The conserved domains and amino acid residues are highlighted in color. The
signal peptidase I cleavage site is indicated; it was predicted by the conserved sequences
of the cleavage sequences in all homologues and based on the known processed sites of F
TraA, RP4 TrbC and At VirB2. The putative hydrophobic transmembrane (TM) helices and
the core regions of all processed VirB2 homologues are indicated as single solid lines and
double dashed lines, respectively. This figure was modified from from Figure3 in “The Tpilus of Agrobacterium tumefaciens.” Trends Microbiol. 8, 361-69. (doi:10.1016/S0966842X(00)01802-3).
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Figure 1.5 Schematic of the pilin processing and proposed T-pilus biogenesis
pathway of the Agrobacterium tumefaciens VirB/D4 secretion system
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown
according to their proposed localization and interactions. VirB2 is produced as a 121 amino
acid pro-pilin that is inserted into the inner membrane. The 47 residue signal sequence is
cleaved by a signal peptidase, resulting in a 74 amino acid product. The N- and C-termini
are joined in a head-to-tail peptide bond, forming a cyclic peptide. The mature pilin is
composed of two hydrophobic domains and two short hydrophilic domains. The cyclized
mature pilin is then predicted to be shunted up the core complex where is can serve as the
building block for assembly of a functional secretion channel and the extracellular T pilus.
P: periplasm; IM: inner membrane; OM; outer membrane; S.S: Signal Sequence.

18

19

T-pili are long, 10nm wide filaments; when treated with sodium dodecyl-sulfate, a 2 nm
channel was detected (104). In such a putative channel, it would be possible for the
monomeric cyclic VirB2 peptides to be transported to the growing tip of the T-pili, in an
assembly mechanism similar to that of flagella. Alternatively, new monomeric protein may
be added at the base of the pilus. Immunogold labeling studies confirmed that VirB2 pilins
comprise the entire length of the T pilus, and also supplied evidence that VirB5 is localized
to the filament tip (121). A VirB4-VirB8-VirB5 interaction sequence was shown to be
required for formation of a VirB2-VirB5 complex; assembly of this complex is thought to be
a prerequisite for T-pilus assembly (122). Beyond this interaction network, little is known
about the subunits involved or the specific steps necessary for T-pilus assembly.
Uncoupling Mutations
Interestingly, various VirB mutations have been isolated that disengage or separate
substrate transfer from T-pilus biogenesis. Mutations have been identified in VirB6, VirB9,
and VirB11 that abolish formation of detectable T-pilus without disrupting secretion of
substrates through the VirB channel (82, 87, 123). In addition, deletion of the VirB1
transglycosylase was shown to abolish T-pilus production without blocking substrate
transfer (124-126), whereas, conversely, deletion of the VirD4 coupling protein does not
affect T-pilus biogenesis but blocks substrate transfer. On the basis of these findings, it has
been proposed that the VirB proteins can alternatively assemble as the T-pilus or the
secretion channel. Signals directing assembly of the VirB proteins as the secretion channel
or the T-pilus are not known, but could include events occurring at the inner face of the
inner membrane e.g. substrate docking, ATP hydrolysis, or the outer face of the outer
membrane, e.g. target cell contact, pilus breakage.

VIII)

The Importance of VirB2 and VirB10 Subunit Studies of the VirB/D4 T4SS
Both VirB2 and VirB10 are required for substrate transfer and T-pilus biogenesis

(25, 127, 128). The movement of VirB2 from the inner membrane to a predicted periplasmic
VirB2 polymer (secretion channel portion) (58, 123) and an elaborate extracellular
organelle, suggests that VirB2 undergoes dynamic changes in structure and protein-protein
contacts. Energy is predicted to play a key role in T-pilus biogenesis but the specific
contributions of the VirB ATPases VirB4 and VirB11 have yet to be defined. Biochemical
assays have shown that VirB10 is an energy sensor that undergoes a conformation change
in response to ATP hydrolysis by VirB11 and VirD4 at the inner membrane (58). Structural
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information on the ‘core’ channel complex of the T4SS encoded by pKM101 showed that a
VirB10 homolog forms the outer membrane pore and spans the entire cell envelope (67,
68). Nevertheless, the structural and functional role of VirB10 domains with respect to Tpilus biogenesis and substrate transfer remain undefined. The location of VirB10 and its
energy sensing capability suggest that VirB10 could gate the outer membrane channel and
VirB10 domains may play specific roles in both secretion and T-pilus assembly. Thus,
studies aimed at characterizing the contributions of the VirB2 pilin and VirB10 energy
sensor during formation of the T4SS will help develop a more detailed mechanistic
understanding of T4SS biogenesis and function, and will also contribute to a broader
comprehension of the energetics and molecular events underlying assembly of complex
surface organelles.

IX)

Dissertation Focus and Specific Aims
In this thesis, I sought to define key reactions required for the integration of the

VirB2 pilin into the secretion channel and T-pilus. My work focused primarily on VirB2,
VirB4, and VirB10, and the 4 aims were: i) define the VirB2 inner membrane topology and
packing architecture in the T-pilus (Chapter 3), ii) characterize the contributions of the VirB4
and VirB11 ATPases to the structural state of membrane-integrated VirB2 pilin during
machine biogenesis (Chapter 4), iii) Characterize how VirB10 domains contribute to T-pilus
biogenesis and channel activity (Chapter 5), and iv) explore the mechanism by which a
VirB10 gating mutant mediates release of secretion substrate while selectively blocking Tpilus biogenesis (Chapter 6).
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Chapter 2: Materials and Methods
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Strains, plasmids, and induction conditions
Agrobacterium tumefaciens and Escherichia coli strains and plasmids used in this
study are listed in Table 2.1 and 2.2.

Conditions for growth of A. tumefaciens and E. coli

and for vir gene induction with 100 µM acetosyringone (AS) in induction media (ABIM) have
been described previously (128). Plasmids were maintained in A. tumefaciens and E. coli
by addition of gentamycin sulfate (100 & 20 µg/ml, respectively), carbenicillin (100 µg/ml),
tetracycline (5 µg/ml), spectinomycinn (600 µg/ml) and kanamycin (100 µg/ml).

VirE2-FLAG tag construction
Cristina Alvarez-Martinez, a postdoctoral fellow in the Christie laboratory
constructed a plasmid expressing PvirB-virE1-FLAG-virE2 by site-directed mutagenesis
using two-step PCR (129). Primers used to construct this plasmid are listed in Table 2.3.
Primers virE1_for_Nde and virE1_rev_FLAG were used to amplify the region upstream of
the FLAG epitope tag (the FLAG sequence was introduced in the virE1_rev_FLAG primer).
Primers virE2_for_FLAG and E2Down were used to amplify the region downstream of the
FLAG tag (primer virE2_for_ FLAG contained the desired tag). The 5’ and 3’ fragments
obtained after PCR amplification were used as templates in another PCR reaction using
primers virE1_for_Nde and E2Down, generating the full-length gene containing the desired
FLAG tag in frame with VirE2. The fragment was cloned in the pGEMT-Easy vector
(Promega) and sequenced.

VirB2-FlAsH tag construction
Plasmids in pJKFlAsHxx series were constructed by cloning a FlAsH Kanr cassette
into the SphI site created by the Cys substitutions in VirB2 (See (130)). FlAsH Kanr cassette
was constructed by PCR amplification of the Kanr cassette from pXZ151 and flanked by an
SphI site, half of the FlAsH tag, and a SmaI site, resulting in: SphI – Cys – Cys – Pro –
SmaI -- Kanr cassette – SmaI – Gly – Cys –Cys -- SphI. Primers used for amplification are
listed in Table 2.3, Following cloning into the SphI site created by the Cys substitutions in
VirB2 (130), the Kanr cassette was removed by SmaI digestion. Imran Shah, a postdoctoral
fellow in the Christie laboratory, constructed plasmids pISFlAsH63 and pISFlAsH114 using
oligonucleotde-directed mutagenesis. Plasmid pBB8 served as the template (128) and the
FlAsH tag was inserted using the primers listed in Table 2.3. Insertions were confirmed by
sequencing.
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TABLE 2.1: Bacterial strains used in these studies.
Bacterial Strain

Relevant characteristics

Source

E. coli
DH5α

λΦ80d/lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1
hsdR17(rK - mK+)supE44 thi-1 gyrA relA1

GIBCO-BRL

S17-1

Tra genes from pRP4 integrated into chromosome

BIO-RAD

A348

A136 containing pTiA6NC

(131)

A348Spcr

A348 with Spcr by spontaneous mutagenesis

(87)

PC1000

A348 deleted of entire virB operon from pTiA6NC

(132)

PC1001

A348 deleted of virB1 and from pTiA6NC

(128)

PC1002

A348 deleted of virB2 from pTIA6NC; polar on virB3

(128)

PC1003

A348 deleted of virB3 from pTIA6NC

(128)

PC1004

A348 deleted of virB4 from pTIA6NC

(133)

PC1005

A348 deleted of virB5 from pTiA6NC

(128)

PC1006

A348 deleted of virB6 from pTIA6NC

(128)

PC1007

A348 deleted of virB7 from pTIA6NC

(128)

PC1008

A348 deleted of virB8 from pTIA6NC

(128)

PC1009

A348 deleted of virB9 from pTIA6NC

(128)

PC1010

A348 deleted of virB10 from pTIA6NC

(128)

PC1011

A348 deleted of virB11 from pTIA6NC

(128)

PC1211

A348 deleted of virB2 and virB11 from pTIA6NC

(123)

JK1002

A348 deleted of virB2 from pTiA6NC

(130)

JK1204

A348 deleted of virB2 and virB4 from pTiA6NC

(130)

C58-fliR

C58 deleted of fliR- Aflagellate, non-motile

Dr. Clay
Fuqua

A. tumefaciens
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TABLE 2.2: Plasmids vectors used in these studies
Plasmid or
Vector

Relevant characteristics

Source

pGEMT-Easy

Crbr; cloning vector

Promega

pBSIIKS+ NdeI

Crbr; cloning vector containing NdeI restriction

(128)

pXZ151

Kanr; broad-host-range IncP plasmid containing Plac
with downstream polylinker sequence

(134)

pSW172

Tetr; broad-host-range IncP plasmid Plac with
downstream polylinker sequence

(128)

pBBR1MCS2Kr

Kanr; broad-host-range cloning vector

(135)

pBBR1MCS2Gr

Genr; broad-host-range cloning vector

(106)

pML122ΔKr

Genr; IncQ RSF1010 derivative

(60)

pBB50

Kanr; ~3-kb BamHI fragment containing nptII

(128)

pJEK01

Crbr; pBIIKS+NdeI expressing PvirB-virB2C64S

(130)

pJEK02

Crbr; pBB8 with a virB2 internal deletion

(130)

virB expression
plasmids

r

r

pJEK03

Crb Kan ; sacB-containing pBB50 (128) with the
ΔvirB2 mutation and flanking sequences from pJEK02

(130)

pPC914

Crbr; pBIIKS+NdeI expressing PvirB-virB1

(128)

pPC927

Crbr; pBIIKS+ expressing PvirB-virB1, virB2 with NdeI at
start site, and virB3

(128)

pKA93

Genr; pBBR1MCS2Gr expressing PvirB-virB4

(45)

pKA96

Genr; pBBR1MCS2Gr expressing PvirB-virB4K439Q

(130)

pKA94

Genr; pBBR1MCS2Gr expressing PvirB-virB4 and PvirBvirB11

(130)

pJKxx series

pJEK01 with VirB2 Cys substitutions; xx denotes the
position of the codon replacement

(130)

pJKBxx series

Crbr Kanr; pXZ151 ligated to pJKxx plasmids

(130)

pJKBBxx series

Crbr Kanr; pBBR1MCS2Kr ligated to pJKxx plasmids

(130)

pXZB100

Crbr Kanr; pXZ151 with PvirB-virB11

(136)
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pPCB39

Crbr Kanr; pXZ151 with PvirB-virB11K175Q

(90)

pXZB102

Crbr Kanr; pXZ151 with PvirB-virB11I265T

(87)

pKVD10

Crbr Tetr; pSW172 with Plac-VirB10

(69)

pKVD116

pKVD10 with residues 2-18 deleted from VirB10

(69)

pKVD136

pKVD10 with residues 2-46 deleted from VirB10

(69)

pKVD117

pKVD10 with residues 70-114 deleted from VirB10

(69)

pKVD145

pKVD10 with residues 72-92 deleted from VirB10

(69)

pKVD146

pKVD10 with residues 92-114 deleted from VirB10

(69)

pKVD126

pKVD10 with residues 268-287 deleted from VirB10

(69)

pKVD129

pKVD10 with residues 308-337 deleted from VirB10

(69)

pIG022

pKVD10 with VirB10 Cys substitution at residue 356 in
the RDLDF motif

(69)

pKVDΔ150

pKVD10 with residues 2-150 deleted from VirB10,
fused to the 5’ end of VirB5 signal sequence from
pZD74

(69)

pZD74

virB5 signal sequence

(69)

pIGxx series

pKVD10 with VirB10 Ala-Cys codon insertions or cys
codon substitutions; xx denotes the codon immediately
preceding the insertion or codon of substitution

(69)

pCM48

PvirB VirE1-VirE2 FLAG in pGEM-Easy vector

(Dr. Cristinta
Martinez,
this study)

pCM50

PvirB VirE1-VirE2 FLAG cloned as a NdeI/XhoI
fragment from pCM48 into pPC914 Nde/Xho

(Dr. Cristinta
Martinez,
this study)

pCMB50

Crbr Kanr; pBBR1MCS2Kr ligated to pCM50 PvirB
VirE1-VirE2 FLAG

(Dr. Cristinta
Martinez,
this study)

pLB100

VirB10 with substitution G272R

Dr. Lois
Banta

pJKFLAG85

pBB8 with VirB2 FLAG insertion following residue 85

This study

pJKFlAsHxx series

pVS10 with VirB2 Cys substitution and FlAsH tag
insertion; xx denotes the Cys substitution FlAsh tag
inserted at the SphI site

This study

pISFLAG62

pBB8 with VirB2 FLAG insertion following residue 62

(Dr. Imran
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Shaw, this
study
pISFLAsH63

pBB8 with VirB2 FlAsH tag insertion following residue
63

(Dr. Imran
Shaw, this
study)

pISFLAsH114

pBB8 with VirB2 FlAsH tag insertion following residue
114

(Dr. Imran
Shaw, this
study)
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Table 2.3: Oligonucleotide primers used for epitope tag construction and insertion
Name

5’Primer

VirE1_for_Nde

5’ – AAT ACA TAT GGC CAT CAT CAA G – 3’

VirE1_rev_FLAG

5’ – TTT GTC GTC GTC GTC TTT GTA GTC CAT CGT CTC
ACT CCT TCT GAC – 3’

VirE2_for_FLAG

5’ – ATG GAC TAC AAA GAC GAC GAC GAC AAA ATG
GAT CTT TCT GGC AAT– 3’

E2Down

5’ – TTC TCG AGT CAA AAG CTG TTG ACG CTT TGG
CTA CG – 3’

FlAsH Kan SphI SmaI-AS

5’ – AAT GCA TGC ACA ACA CCC GGG GTC GAC CTG
CAG – 3’

FlAsH Kan SphI SmaI -S

5’ – AAT GCA TGC TGC CCC GGG TGA GGT CTG CCT C

B2FlAsH 63/64-S

5’ – GCT GCC CAG GAT GCT GCA TAT GCA GCT TTA
TCC TTG GTC C – 3’

B2FlAsH 114/115-AS

5 ’– GCA GCA TCC TGG GCA AGC AGC CGA GGA AGC
TCG CCC C – 3’

B2FLAG 59/60-AS

5 ’– CGT GCA TAT ATT GTT AAC CTT GTC ATC GTC GTC

B2FLAG62/63-S

5’- GAT TAT AAA GCG TTT GAT AAC CTG ATA TGC ACG
TTT ATC CTT GGT CC – 3’

B2FLAG 64/65-AS

5’ – CGG ACC AAG GAT AAA CGT CTT GTC ATC GTC
GTC GTC CTT ATA ATC GCA TAT ATT GTT AAC CAT – 3’

B2FLAG 85/86-AS

5’- CCG CCC GAA CAT CCA GGA CTT GTC ATC GTC
GTC CTT ATA ATC GAT CCC GAT AGC GAC AAT – 3’

B2FLAG 118/119-AS

5’- TCA ACT ACC GCC CTT GTC ATC GTC GTC CTT ATA
ATC AGT GAG CGT TTG GCC GAG – 3’
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VirB2-FLAG tag construction
Plasmid pBB8 served as the template for construction of the FLAG tagged VirB2
insertion mutations using oligonucleotde-directed mutagenesis (128) and the FLAG tag was
inserted using the primer listed in Table 2.3. Imran Shah, a postdoctoral fellow in the
Christie laboratory constructed plasmid pISFlag62.

Virulence assays
Strains of A. tumefaciens were tested for virulence on wounded Kalanchoe
daigremontiana leaves (128). Controls for the tumorigenesis assays included co-inoculating
the same leaf with wild-type A348 and the corresponding vir gene deletion. Virulence was
scored in terms of and time course of tumor appearance and tumor size. Tumors were
scored on a scale of – avirulent to +++ wild-type virulence. Assays were performed in
triplicate.

Conjugation assays
Diparental mating with E. coli strain S17-1(pML122) was used to introduce the IncQ
plasmid pML122 (Genr) into various A. tumefaciens donor strains (82, 87). Conjugative
transfer of the mobilizable IncQ plasmid pML122Genr from A. tumefaciens donor strains of
interest to A348Spcr recipient cells was carried out as described previously (87). Assays
were performed in triplicate and transfer frequencies presented as the number of
transconjugants per donor for a representative experiment.
Protein analysis and immunobloting
Proteins

were

resolved

by

sodium

dodecyl

sulfate

polyacrylamide

gel

electrophoresis (SDS-PAGE) using 12.5% or 10% polyacrylamide gels, or Tricine sodium
dodecyl sulfate polyacrylamide gel electrophoresis (Tricine SDS-PAGE) using 16.5%
polyacrylamide gels (84).

Gels were transferred to nitocellullose membranes, and

visualized by immunoblot development with goat anti-rabbit conjugated to alkaline
phosphatase (BioRad) or blots were developed with anti-rabbit antibodies conjugated to
horseradish peroxidase and were visualized by chemiluminescence (Pierce, Thermo
Scientific). Pre-stained SDS-PAGE Broad Range from BioRad served as the molecular size
markers.
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T-pilus isolation and extracellular blot assay
A. tumefaciens strains were grown to an OD600 of 0.5 in MG/L media at 28 °C, and
then induced for expression of the vir genes with acetosyringone (AS) at 25 °C, as
described previously (137). The induced culture (1 mL) was spread on ABIM agar plates
and incubated for 4 d at 18 °C. Cells were removed from the plates and placed in 1 ml 50
mM KPO4 buffer (pH 5.5). The cell suspension was passed through a 25-gauge needle.
The sheared material was centrifuged for 30 min at 14,000 x g at 4 °C and the supernatant
was saved. The fraction was centrifuged for 1 h at 100,000 x g at 4 °C to recover T- pili or
alternatively prepped for analytical gel filtration or viewing in the electron microscope (refer
below). T-pili were suspended in 50 μL of Laemmli's buffer and boiled, or suspended in
buffer A [100 mM Hepes (pH 7.5), 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl] and further
fractionated through a 20-70% sucrose density gradient as described previously (138).
Alternatively, resuspended T-pili were used in Cys labeling studies, as described below.
Extracellular VirB2 and VirB5 were detected by colony surface immunoblotting as described
previously (69).
Analytical gel filtration
Recovered T-pili samples were subjected to analytical gel filtration (AGF) by Dr.
Hye-Young Yeo (University of Houston) using a Superdex 75 10/300GL column (Tricorn)
(69). The column was equilibrated and run with buffer S [50mM Hepes pH 7.0, 2mM MgCl2,
5% glycerol, 100mM NaCl, 0.1mM EDTA].

The AGF column was calibrated using

molecular weight standard markers RNase A (14kDa), chymotrypsinogen A (25kDa),
albumin (67kDa), and lactate dehydrogenase (140kDa) (Amercham Biosciences).
Recovered gel filtration factions were analyzed using tricine SDS-PAGE as mentioned
above.
Chemical labeling of cysteine residues
Cysteine labeling experiments were performed as previously described (65) with
some modifications. Briefly, A. tumefaciens strains producing VirB2 Cys derivatives were
induced for vir gene expression and grown to an OD600 of 0.6. Cells from 30 ml cultures
were harvested, resuspended in buffer A and distributed into two oakridge tubes to a final
OD600 of 12 in 500 μl of buffer A. 4-acetamido-40-maleimidylstilbene-2,20-disulfonic acid
(AMS; Molecular Probes) was added (5 mM final) to one cell suspension, and cells were
incubated at 25 °C for 30 min. Ten ml of buffer A was added to the cell suspension and
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centrifuged to remove the AMS. The resulting cell pellet was resuspended in 500 μl of
buffer A. 3-(N-maleimidylpropionyl) biocytin (MPB; Molecular Probes) was added to the
AMS-pretreated cells and the second cell suspension at a final concentration of 100 μM (20
mM stock in dimethyl sulfoxide). The cells were incubated at 25 °C for 5 min. The final
concentration of dimethyl sulfoxide in the reaction did not exceed 0.5% (v/v).The
biotinylation reaction was quenched by addition of β-Mercaptoethanol (β-ME; 20 mM final)
and cells were washed two times in buffer A with 20 mM β-ME. As controls, sonicated cell
extracts were treated with MPB. For labeling of the T-pilus, enriched T-pili were suspended
in 500 μl of buffer A, treated with a final concentration of 100 μM MPB, and incubated at 25
o

C for 5 min. The biotinylation was stopped by addition of β-ME (40 mM final). T-pili were

recovered by centrifuging at 100,000 x g, and MPB labeling of Cys-substituted pilin was
assessed as described below.
Detection of labeled cysteine residues
MPB-treated T-pili or whole cells were suspended in 200 μL TES buffer [10 mM Tris
pH 7.5, 5 mM EDTA, 2% (w/v) SDS] and vortexed at 37 °C for 30 min. Samples were
incubated on ice for 1 h with 250 μl of buffer B [150 mM Tris (pH 8.0), 0.5 M sucrose, 10
mM EDTA] plus lysozyme (1mg/ml final). Sample were then vortexed at 37 °C for 15 min.
Triton X-100 (20 μl), 13 μL of 1 M MgCl2 stock solution, and protease inhibitor cocktail
EDTA-free (30 μl; Pierce Biochemicals) were added and the samples were vortexed at 25
°C for 10 min followed by gentle rocking at 4 °C for 3 h. Samples were diluted with 900 μl
of buffer B and centrifuged at 14,000 × g for 15 min. The resulting supernatant was
incubated with a 30 μl bed volume of Protein A-Sepharose CL4B (Pharmacia) at 25 oC and
for 45 min and centrifuged at 5000 × g to remove protein A-Sepharose and non-specifically
bound proteins. The recovered supernatant was incubated overnight at 4 °C with a 60 μl
bed volume of Protein A-Sepharose coupled to anti-VirB2 antibodies. The beads were
recovered by low-speed centrifugation at 400 x g and washed two times in buffer B plus 1%
(w/v) Triton X-100 at 4 °C for 10 min, one time in buffer B plus 0.1% (w/v) Triton X-100 at 4
°C for 10 min, and one time in buffer B at 25 °C for 5 min. Beads were recovered and 15 μL
buffer B plus 15 µl of 5X Laemmli’s buffer was added prior to boiling samples (5min).
Boiled samples were centrifuged at 400 × g for 5 min and proteins were subjected to
Tricine-SDS-PAGE and transferred to nitrocellulose as described above. Membranes were
blocked with buffer C [1X PBS, 0.1% Tween 20, 5% (w/v) bovine serum albumin (BSA)]
overnight and then for 4 h in the presence of avidin-HRP (Pierce; 2:10,000 dilution from 2
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mg/ml stock). Blots were washed 3 times in buffer D (1X PBS, 0.1% Tween 20, 0.5% BSA)
and incubated for 10 min with buffer C prior to analysis by chemiluminescence according to
the manufacturer’s instructions (Pierce, Thermo Scientific).
Growth Curves
A. tumefaciens strains were grown to an OD600 of 0.5 in MG/L media at 28 °C, and
then induced in ABIM at 25 °C for 4 h. Cells were normalized and diluted in ABIM (OD600=
0.1). Greinier Bio-One flat-bottom, 24- well PS microplates (Sigma-Aldrich, Prague, Czech
Republic) were filled with the cell suspension (1mL in each well). Plates were covered with
a sealing membrane (Breathe-Easy; Sigma-Aldrich). Growth over time (18 h) was
monitored using a SynergyTM Mx Multi-Mode Microplate Reader (Biotek Instrucments). The
absorbance in each well was measure at 600 nm at given intervals (30 min) with continuous
shaking of the microplate. The absorbance data, with background absorbance subtracted,
were exported to MS Excel for further processing. Data are shown for a representative
experiment.
FLAG-VirE2 Release Screen
Surface-exposed FLAG-VirE2 was detected by colony immunoblotting as described
previously for VirB2 detection (69) with minor modification. Monoclonal FLAG antibody was
used as the primary antibody followed by immunoblot development with goat anti-mouse
conjugated to alkaline phosphatase (BioRad).
Assays for vancomycin and SDS sensitivity
Growth of each strain in ABIM supplemented with 0.5% SDS or Vancomycin (50
μg/ml and 100 μg/ml) was monitored over 18 h using Synergy™ Mx Multi-Mode Microplate
Reader (BioTek Instruments) as described above.
Assays for outer membrane integrity
RNase I release from intact cells was assayed according to Lazzaroni and Portalier
(139). Briefly, ABIM induced cells were normalized (OD

600

= 0.6) and 20 μl was spotted

on ABIM RNase agar [standard ABIM agar supplemented with 0.1% yeast extract and 1%
RNA type VI from Torula yeast (Sigma)]. After overnight growth at 28 oC, RNA was
precipitated with cold 10 % trichloroacetic acid (TCA), and RNase I leakage was detected
by identification of clear zones surrounding colonies.

Alternatively, after overnight

incubation, colonies were scraped from the plates, resuspended in 50 μl ABIM, and
sonicated. Lysed cells were spotted on fresh ABIM RNase agar for 1h prior to TCA
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precipitation and monitored for clearing. ChvE release was monitored by colony
immunobloting with anti-ChvE antibody (69). Alternatively, after incubation, colonies were
scrapped from the plates, resuspended in 50 μl ABIM, and sonicated. Lysed cells were
spotted on 0.45 mm nitrocellulose membrane, allowed to sit for 5 min, and developed by
immunostaining as mentioned above (69).
Co-immunoprecipitation
Coimmunoprecipitation was performed as described previously (82). Briefly, 500 ml
cultures induced by AS were harvested and cells were lysed by the French press.
Ultracentrifugation was used to recover total membranes. Membrane were cross-linked
with dithiobissuccidimidyl propionate (DSP; 0.5 mg /ml final) and solubilized with RIPA
buffer (50 mM Tris pH 7.6, 0.1% SDS, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP40). The solubilized membranes were used in immunoprecipitation experiments probing
with anti-VirB2, anti-VirB4, or anti-VirB11 antibodies coupled to Protein A-Sepharose CL-4B
beads (Amersham Biosciences).
Osmotic shock
Cells were subjected to osmotic shock treatment as previously described (140).
Briefly, A. tumefaciens strains were induced and grown to an OD600 of 0.5. Cells from 65 ml
cultures were harvested and normalized to final OD600 of 18. Cells were pelleted by
centrifugation at 10,000 x g, resuspended in 8 ml of ice-cold osmotic shock solution [20%
(w/v) sucrose, 5 mM CaCl2, 33 mM Tris–HCl pH 8.0, 0.5 mM Na2 EDTA] and incubated
while shaking at 4 °C for 15 min. Cells were pelleted by centrifugation at 10,000 × g for 10
min and the supernatant was removed.

The pellet was resuspended in 1 ml ice-cold

reverse osmosis water and incubated at 4 °C for 10 min while shaking.

The cell

suspension was centrifuged at 8000 x g for 10 min, and the osmotic shockate
(supernanant) was recovered and the cell pellet was reserved. The shockate was
concentrated by precipitation with 5 % trichloroacetic acid or alternatively by
ultracentrifugation at 100,000 x g at 4 °C for 1 h. the resulting pellet was resuspended in 20
μl of 5X Laemmli’s buffer. The remaining cell pellet was resuspended in 400 μL 5X
Laemmli’s buffer. Samples were boiled (5 min) and then analyzed using 12.5% SDS-PAGE
and Tricine SDS-PAGE as described above.
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Electron microscopy
T-pili in the saved supernatant from ABIM plates, mentioned above, were
precipitated with 1M MgCl2 (0.1 M final) by incubation overnight at 4 °C. T-pili were
collected

by centrifugation at 16,000 x g at 4 °C for 1.5 h. The resulting pellet was

resuspended in 100μl of 10 mM Tris-Cl (pH 8.0) and further fractionated through a 20-70%
sucrose density gradient at 99,000 x g at 4 °C for 4 h. Fractions (~400 μl) containing T-pili
were pooled and centrifuged at 100,000 x g at 4 °C for 1 h. The pellet was resuspended in
100μl 10 mM Tris-Cl (pH 8.0) and fractionated through a 1.1-1.5g/mL CsCl step-gradient for
at 120,000 x g at 5 °C 18 h (115). Fractions (~250 μL)harboring T-pili were pooled and
centrifuged at 100,000 x g at 4 °C for 1 h. The pellet was resuspended in 10 mM Tris-Cl
(pH 8.0) and further diluted to 4 mL to remove excedd CsCl prior to centrifuging at 100,000
x g at 4 °C for 1 h. The final pellet was resuspended in 50 μL of 50 mM Hepes, a 5 μl
sample was placed on a 300-mesh carbon-Formvar grid (Ted Pella, Inc.). Grids were
stained with 1% uranyl acetate (Ted Pella, Inc.) and examined with a JOEL 1400 electron
microscope.
Disulfide crosslinking
Isolated T-pili (as described above) were resuspended in non-reducing Laemmli's
buffer [125 mM Tris-HCl, pH 6.8, 20% (v/v) glycerol, and 4% (w/v) SDS) containing 50 mM
EDTA and no reducing agent] or standard β-ME-containing Laemmli's buffer, boiled, and
electrophoresed through a Tricine SDS-PAGE gel, as described above.

Alternatively,

isolated T-pili were suspended in PBS (pH 7.4), and samples were cross-linked by
incubation with 1 mM Cu2-(phenanthroline)3 as the oxidant at 37 °C for

5 min. The

reactions were stopped by addition 5 mM EDTA followed by addition of non-reducing
Laemmilis’ buffer. Samples were subjected to Tricine-SDS PAGE gels and proteins were
detected as described above.
Immunofluorescence microscopy
Cells induced with AS for synthesis of the Vir proteins were washed once in 1 X
phosphate buffered saline (PBS; 150 mM NaCl, 15 mM KCl, 0.11% Na2HPO4, 0.03%
NaH2PO4) and a 30 μl suspension (OD600=2) was applied onto a 0.1% poly-L-lysine-coated
glass cover slip and briefly air dried. Cells were fixed by incubation overnight at 25 °C in
fixation solution (37.5% methanol + 12.5% acetic acid), and unbound cells were removed
by three 20 min washes in PBS containing 0.05% Tween-20 (PBS-T). Cells were treated
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overnight at 4oC with primary antibodies (1:100 dilution in 2% BSA), followed by three PBST washes. Cells were then incubated in the dark with Alexa fluorR 488 goat-anti-rabbit IgG
(1:100 dilution in 2% BSA) (Molecular Probes) at 25 °C for 1 h. Cells were washed one
time with PBS-T and two times with PBS. Cover slips were treated with anti-fade solution
(50% glycerol in PBS), sealed with base coat of nail polish (Revlon) on a microscopic slide,
and visualized Nomarski microscopy.
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Chapter 3: T-pilus Maturation as Monitored by Cysteine Accessibility

NOTE: This chapter is derived from work that has been published in 2010: “Evidence for
VirB4-Mediated Dislocation of Membrane-Integrated VirB2 Pilins during Biogensis of the
Agrobacterium VirB/VirD4 Type IV Secretion System.” Journal of Bacteriology 192(19):
4923-34. PMID: 20656905.

I am the primary author on this paper. I performed all

experiments described in this chapter. I have been given permission by the publisher of
Journal of Bacteriology, the American Society for Microbiology, to reproduce any/all of my
manuscript in print or electronically for the purposes of my dissertation (License Number
2510961139325).
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Introduction
A fundamental question of interest for bacterial surface organelles is how the
machine subunits are processed and delivered to their sites of assembly.

In A.

tumefaciens, VirB2 is an essential component of the two organelles elaborated by the
VirB/VirD4 type IV secretion system (T4SS), the membrane-spanning translocation channel
and the extracellular T-pilus (25, 31, 141). The assembly of VirB2 into the channel and Tpilus is poorly understood, although a few early processing reactions have been
biochemically defined.

Upon synthesis, VirB2 pro-pilin is first integrated into the inner

membrane and then cleaved of its 47-residue signal sequence. Next, the N- and C-termini
are covalently joined by a novel head-to-tail cyclization reaction (115). The protein
catalyzing cyclization has not been identified in A. tumefaciens, but in E. coli the VirB2
homolog TrbC (24/51 % identity/similarity) of plasmid RP4 (115, 142, 143) is also cyclized
and the cyclization reaction is carried out by the TraF protein (115). Cyclization of VirB2
and TrbC is required for functionality of these pilins, whereas another VirB2 homolog, TraA
(19/47 % identity/similarity) of E. coli plasmid F (113), is not cyclized although its N terminus
is N-acetylated (144).
Despite differences in these early processing reactions, a common feature of T4SSencoded pilus biogenesis pathways is that the pilin subunits integrate into the inner
membrane as a pool for subsequent use in building the pilus. Topology models for VirB2,
TraAF, and TrbCRP4 were developed from computer-derived hydropathy profiles and limited
reporter fusion studies with periplasmically-active alkaline phosphatase (PhoA) (144, 145).
These profiles generally predict that two hydrophobic domains of these pilins span the inner
membrane, resulting in localization of hydrophilic terminal domains in the periplasm and
small central hydrophilic loops in the cytoplasm. However, these hydropathy predictions
are often only 60-70% accurate in predicting topology organization (146), and computer
algorithms also do not account for interactions between transmembrane (TM) helices,
contacts with another subunit(s), and/or specific lipid - protein interaction(s) (146-148).
Strategies used to verify membrane protein topologies often rely on general principles
including: impermeability of the membrane bilayer to hydrophilic molecules, the difference
in properties between the compartments separated by the membrane, or incorporation of
reporter groups whose orientation is thought to reflect the topology of the protein (146,
149). While there are other methods available to experimentally determine VirB2’s
predicted protein topology, cysteine scanning remains one of the least invasive and is less
likely than other methods to perturb function and overall structure (149).
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If we consider the membrane-integrated pool of VirB2 as a starting-point in a pilin
assembly pathway, the secretion channel and T-pilus represent the terminal organelles.
VirB2 is required for substrate transfer, even in cells that do not elaborate T-pili (123).
Moreover, on the basis of a demonstrated close contact with translocating T-DNA and
associated genetic studies (58) we predict that the pilin subunit is delivered to and
comprises part of the distal region of the secretion channel near the outer membrane. With
regard to the T-pilus, nothing is known about the pilus structure or the packing geometry of
pilin. However, studies of the related TraAF pilin have led to a proposal that the two αhelices comprising the TM domains form anti-parallel helix-helix interactions in the F-pilus
resulting in surface-exposed N- and C-termini and a charged central domain lining the pilus
lumen (145).
Here, I sought to exploit the power of the substituted cysteine accessibility method
(SCAM) to define the inner membrane topology of VirB2, and then to identify differences in
the structural states of the pilin when assembled as a component of the secretion channel
vs. the T-pilus. This work represents the first detailed in vivo structural analysis of the VirB2
pilin.
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Results
Phenotypes of VirB2 Cysteine Substitution Mutations
Native VirB2 contains 3 Cys residues, two within the signal sequence and Cys64 in
the mature protein. The Christie laboratory reported in an earlier study that a Ser
substitution of Cys64 results in an attenuated virulence phenotype (87). In those studies,
virulence assays were carried out at room (25 oC) temperature; however, more recent
studies have shown that the VirB/D4 T4SS functions optimally at 18 – 20 oC (150). At this
lower temperature, I determined that the C64S mutant exhibits near wild-type substrate
transfer frequencies, as monitored by two assays, virulence on plants and conjugative
transfer of an IncQ plasmid to agrobacterial recipient cells (Fig. 3.1B). T-pili produced by
the C64S mutant at the lower temperature also were indistinguishable from pili from the wild
type strain, as monitored by sucrose density gradient fractionation and electron microscopy
(Fig. 3.1C and D). The wild-type properties of the C64S mutant enabled its use as a
platform for construction of single Cys substitution mutations at 5-7 residue intervals along
the length of VirB2.
In initial phenotypic studies, I determined that all 16 Cys mutant proteins migrated at
the same position and most accumulated at comparable steady-state levels as native VirB2
with minimal to no effect on function, as monitored by pilus production and DNA transfer
(Fig. 3.1). However, two mutant proteins (G51C and T54C) accumulated at diminished
levels in whole cell extracts, although both proteins were detectable in membrane fractions
(Fig. 3.1A). These mutations, as well as T58C, L117C, and G119C which reside near N/C
processing and cyclization sites, completely abolish substrate transfer (Fig. 3.1B). Cys
substitution of the aromatic residue F71 also abolished substrate transfer. Of these
mutations, only G51C, F71C, and L117C also completely abolished T-pilus biogenesis (Fig.
3.1B). Notably, the transfer minus (Tra-) strain producing the G119C mutant pilin assembled
morphologically wild-type pili as monitored by sucrose fractionation and electron
microscopy (Fig. 3.1C and D). This mutant therefore selectively blocks substrate transfer
without detectable effects on pilus biogenesis.
Inner Membrane Topology of VirB2
VirB2 contains two hydrophilic regions and two hydrophobic stretches. For the
purposes of discussion, I will depict VirB2 as consisting of 4 domains (I-IV). This domain
architecture derives from in silico hydropathy analyses (Fig. 3.2A), and is consistent with
that described for the VirB2 homolog, TraA pilin of the F plasmid T4SS (151, 152).
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Figure 3.1 Phenotypes of VirB2 Cys substitution mutations.
(A) Effects of mutations on total cellular and membrane levels of VirB2. Total cellular
material and membrane fractions were subjected to SDS-PAGE, and immunoblots were
developed with anti-VirB2 antibodies. Protein samples were loaded on a per-cell-equivalent
basis. (B) Upper panel, effects of mutations on T-DNA transfer as monitored by virulence
on wounded Kalanchoe leaves (black bars) (–, avirulent; +++, WT virulence) and transfer of
the mobilizable IncQ plasmid pML122 to A. tumefaciens recipients (gray bars) (Tc's/Donor,
number of transconjugants per donor cell). Lower panel, effects of mutations on T-pilus
production, as monitored by VirB2 abundance recovered from the shear fraction by
ultracentrifugation (top) and colony immunoblots developed with anti-VirB2 antibodies
(bottom). (C and D) Pilin fractionation profiles and pilus morphologies produced
by ΔvirB2 mutant strains synthesizing native VirB2 (Cys64; WT) or the Cys64Ser (C64S) or
Gly119Cys (G119C) mutant protein. (C) Distribution profiles of extracellular pilins in
identically prepared 20 to 70% sucrose density gradients, as monitored by immunoblot
development with anti-VirB2 antibodies. (D) Morphologies of pili from peak sucrose gradient
fractions, as detected by uranyl acetate staining and electron microscopy.
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Figure 3.2 MPB accessibility of Cys substitutions.
(A) Predicted domain architecture of VirB2. Numbers correspond to the N and C termini of
mature pilin and a compilation of hydrophobic domain (gray cylinders) boundaries as
predicted by computer hydropathy programs: TMHMM (boundaries predicted: TM1 66 and
88, TM2 92 and 114), Mobyle (70 and 90, 93 and 113), Phobius (65 and 87, 94 and 113),
SOUSI (61 and 83, 91 and 113), and HMMTOP (63 and 85, 92 and 114). Domain
numbering (I to IV) follows the nomenclature devised for the VirB2 homolog, TraA, of the F
plasmid (117). (B) Δ virB operon strains producing pilins with Cys substitutions at the
residues indicated were treated with thiol-reactive MPB without and with pretreatment with
AMS. Cys-substituted pilins were isolated by immunoprecipitation and analyzed for MPB
labeling. Immunoprecipitates also were analyzed for VirB2 protein abundance by blot
development with anti-VirB2 antibodies (ΔB2). (C) MPB labeling profiles obtained by
treatment of intact and lysed cells (by sonication) at neutral and alkaline pH. (D) A topology
model for membrane-integrated VirB2 pilin. Thick black-outlined circles with gray centers,
Cys substitution mutations at these positions were labeled by MPB treatment of intact cells;
thick black-outlined circles with white centers, substitutions at these positions were not
labeled under any condition; gray circles with gray outlines, substitutions labeled upon
sonication (Cys94) or MPB treatment at alkaline pH (Cys64). Peri, periplasm; IM, inner
membrane; Cyto, cytoplasm. Bar, N-C cyclization junction.
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As shown in Fig. 3.2A, it has been proposed that hydrophobic domains II and IV
form transmembrane α-helices and hydrophilic domains I and III reside in the periplasm
and cytoplasm, respectively. To examine the disposition of the pilin at the inner membrane
(IM), I analyzed the accessibility of the substituted Cys residues to the biotinylated
sulfhydryl-specific maleimide probe MPB. MPB has a molecular size of 542 daltons and
crosses the outer membrane (OM) through porins, but inefficiently traverses the inner
membrane (153-155).

MPB therefore labels residues located in the periplasm but not

residues located in the cytoplasm or those buried in transmembrane regions or structural
folds. VirB2 has been shown to undergo processing, cyclization, and membrane insertion
independently of other VirB proteins (156). Thus to define the inner membrane topology of
the cyclized pilin, I developed an MPB-labeling profile for Cys substitution mutants
produced in the ΔvirB operon strain.
As shown in Fig. 3.2B, upon treatment of whole cells, Cys residues throughout
Domain I were MPB-labeled. To confirm the periplasmic location of hydrophilic Domain I, I
pretreated cells with the highly hydrophilic, non-biotinylated sulfhydryl-specific maleimide
probe AMS, which also crosses the OM but not the IM. Labeling of Domain I Cys residues
was efficiently blocked by AMS pretreatment. Curiously, MPB did not label Cys64 in
Domain I even though neighboring Cys substitutions were labeled (Fig 3.2 B). To examine
the possibility that Cys residue may be buried in a structural fold within the periplasmic loop,
MPB-labeling was carried out at alkaline pH 9.5. This alkaline reaction condition has been
shown to render Cys residues in a structural fold - but not those embedded in the
membrane - accessible to MPB labeling (155). As shown in Fig. 3.2 C, Cys64 but not Cys
residues in the TM helices were labeled, supporting the proposal that Cys64 is buried in a
pH-sensitive structural fold.
Cys substitutions present in the hydrophobic Domains II and IV or in the small
hydrophilic loop III (Domain III) were not MPB-labeled in alkaline or neutral conditions (Fig.
3.2C). However, MPB treatment of sonicated cell extracts resulted in the labeling of Cys94
(Fig. 3.2 C), suggesting that Domain III is cytoplasmically localized.

Cys residues in

Domains II and IV were not detectably labeled in whole cells or sonicated cell extracts,
supporting predictions that these correspond to membrane α−helices.
Taken together, these MPB-labeling patterns favor a membrane topology model
depicted in Fig. 3.2 D. This model is consistent with the positive-charge-inside rule for
membrane proteins (157) since Domain III (GR+ASL) has an overall net positive charge.
This model is also compatible with earlier predictions that the cleavage and cyclization
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reactions (Domain I) for the related pilin TrbC of the RP4 T4SS are carried out in the
periplasm (115).

SCAM Reveals VirB2 Topology Changes in the Presence of Other Secretion Subunits
In the above studies, the membrane topology of VirB2 was determined in a strain
lacking other VirB proteins.

I predict that this topology model is also valid for pilin

monomers that accumulate in the membrane as a pool early during T4SS biogenesis in
wild-type cells. I next sought to identify differences in the VirB2 structural organization when
produced together with the other T4SS subunits; any differences detected with the Cyslabeling profile presented above might reflect the altered structural organization of VirB2
when assembled as a component of the secretion channel. I detected differences in MPBlabeling patterns for 3 of the Cys substituted pilins when produced in ΔvirB2 (presence of
VirB proteins) vs. ΔvirB operon (absence of VirB proteins) mutant strains (Fig. 3.3 A).
Specifically, Cys51 in hydrophilic Domain I was not detectably labeled in the presence of
VirB proteins but was strongly labeled in their absence. Conversely, Cys64, also in Domain
I, was strongly labeled in the presence of VirB proteins but was unlabeled in their absence.
Finally, and most strikingly, Cys94, in the hydrophilic loop Domain III, was labeled in in the
presence other VirB proteins even when intact cells were MPB-treated, whereas as shown
above Cys94 was only labeled upon sonication of cells lacking other VirB proteins. We
previously demonstrated, using the same experimental protocol, that Cys substitutions in
the cytoplasmic regions of bitopic protein VirB10 (69) and polytopic protein VirB6 (65) were
not MPB labeled during treatment of intact cells but were labeled in cell lysates. These
data suggest that Cys94 MPB-labeling, observed in a functionally wild-type strain, is
unlikely attributable to cell rupture or permeation of MPB across the inner membrane.
Remaining Cys mutant proteins exhibited the same labeling patterns in both the ΔvirB2 and
ΔvirB operon mutant backgrounds (refer to figure 3.2).
Although the differences in MPB-labeling of Cys51, Cys64, and Cys94 observed in
strains producing vs lacking VirB proteins could reflect differences in the membraneintegrated vs secretion channel form of VirB2, the former strain also produces T-pili. T-pili
are rarely detected on the surfaces of intact cells but are instead readily sloughed into the
extracellular milieu. Nevertheless, I sought to characterize the structural organization of
pilin in a strain that produces a functional secretion channel but lacks extracellular T-pili.
Such strains have been isolated previously in the Christie laboratory as a result of
mutations generated in various VirB subunits including VirB6, VirB9, VirB10, and VirB11
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Figure 3.3 Disposition of VirB2 in VirB-producing cells and T-pili
(A) Comparison of MPB labeling patterns of Cys-substituted pilins synthesized in the
absence (ΔvirB) or presence (ΔvirB2) of other VirB proteins and Pilins (B2*) carried Cys
substitutions at the residues indicated at the tops of the blots. Intact cells and cell lysates
were MPB treated and analyzed as described in the text. VirB2 protein abundance in
immunoprecipitates was assessed by immunoblot analysis with anti-VirB2 antibodies (ΔB2).
Schematic diagrams of MPB labeling patterns are presented below the blots for each strain.
Thin lines, hydrophilic loops; gray cylinders, hydrophobic domains; bar, cyclization junction;
black-filled circles, MPB labeled upon treatment of intact cells; gray-filled circles, no MPB
labeling. IM, inner membrane. Data are presented only for Cys replacements displaying
differences in labeling patterns between the two genetic backgrounds. (B) the patterns in an
uncoupler mutant (B11-I265T) that does not produce T-pili but is substrate positive. (C)
MPB labeling patterns of pilins incorporated into the T-pilus. Corresponding colony
immunoblots developed with anti-VirB2 antibodies are shown for each mutant strain. The
schematic at the right shows MPB accessibility of Cys residues in the isolated T-pilus. Black
and gray circles, accessible and inaccessible residues, respectively.
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(69, 82, 87, 123).

These Tra+, Pil- mutations are postulated to ‘uncouple’ pathways

mediating assembly of the T-pilus and the secretion channel and therefore are termed
‘uncoupling’ mutations. Importantly, mutant strains with the Tra+, Pil- phenotype still require
VirB2 for substrate translocation (123), indicating that the pilin is a component of the
secretion channel.
I introduced these three Cys-substituted pilin genes into a strain producing a VirB11
mutant (I265T) that confers the Tra+, Pil- “uncoupling” phenotype (87). Upon treatment of
these strains, I found that the Cys-substituted pilins exhibited the same MPB-labeling
patterns as observed for strains producing native VirB11 together with the other VirB
proteins (Fig. 3.3 A and B). The differences in MPB-labeling of Cys51, Cys64, and Cys94 in
strains lacking vs. producing other VirB proteins therefore likely reflect differences in
structural organization of the pilin when integrated in the membrane vs assembled as a
component of the secretion channel.
The T-pilus is the alternative terminal organelle produced during T4SS biogenesis. I
sought to examine the pilin structural organization when polymerized as the T-pilus, and to
this end I isolated T-pili from the Pil+ strains producing Cys-substituted pilins.

MPB

treatment of the isolated T-pili yielded a labeling profile that was in stark contrast to that
obtained for the cell-associated pilins. In the T-pilus, Cys residues at positions 64 and 67 in
hydrophilic Domain I and position 77 in hydrophobic domain II were labeled (Fig. 3.3 C).
Other Cys residues in Domain I (at positions 54, 58, and 119) and Cys94 in Domain III did
not MPB label upon treatment of isolated T-pili (Fig. 3.1 B & 3.3 C). These data suggest
that hydrophilic and hydrophobic residues 64-77 in Domains I and II, respectively, are
surface-displayed in the T-pilus. Other residues in Domain II, and those in Domains III and
IV, were MPB-inaccessible and therefore likely buried in packing interfaces or the lumen of
the T-pilus.
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Discussion
Here, I developed a topology model for the membrane-integrated VirB2 pilin by
SCAM. I then used SCAM to identify differences in the structural organization of pilin when
it is incorporated as part of the VirB/D4 T4SS machine. My data supplied the first evidence
that VirB2 adopts distinct structural states when assembled as a component of the
secretion channel vs. the T-pilus.

I discuss my findings below in the context of available

data on other conjugative pili.
The topology model derived from my MPB labeling studies was for VirB2 pilin
produced in the absence of other VirB proteins. The data confirmed and extended previous
studies of VirB2 and the related pilins TraAF and TrbCRP4 based on in silico secondary
structure analyses and PhoA fusion studies (152, 158, 159). Essentially, I found that the
two hydrophobic regions (domains II and IV) span the IM, the intervening hydrophilic loop
(domain III) is located in the cytoplasm, and a large hydrophilic region comprised of N- and
C-terminal hydrophilic residues joined by cyclization (domain I) is located in the periplasm
(31, 143, 152). The general model for biogenesis of T4SS pili is that the pro-pilin subunit
integrates into the inner membrane and is then processed into the mature pilin.

Pilin

monomers then accumulate in the membrane until a signal that is currently unknown
activates pilin dislocation and subsequent assembly reactions. Although the formation of a
pilin pool remains untested for the A. tumefaciens VirB/VirD4 T4SS, at this point it is
reasonable to assume that the topological profile of pilin synthesized in the absence of
other VirB proteins corresponds to that of the pilin pool in wild-type cells. It is important to
test the pilin pool model and studies presented in the Future Studies section (see Chapter
7) are designed to evaluate this model.

Contribution of Domains and Residues to VirB2 Function
Mutational studies of VirB2, as well as TraAF and TrbCRP4, have identified residues
generally in the hydrophilic loops that are critical for pilin processing, stability, and function
(Fig. 3.4) (160, 161). VirB2 mutations within the signal sequence near the cleavage site
disrupt processing of the pro-protein and cyclization (115) and similar results have been
seen with TraAF and TrbCRP4 (Fig. 3.4). Here, I found that Cys substitutions near the Nterminus of the mature pilin (Cys51, Cys54) disrupted protein stability (Fig. 3.1) Mutations
within both the N- and C-termini of VirB2 that do not appear to affect processing, also
resulted in loss of substrate transfer (Cys51, Cys54, Cys58, Cys117, Cys119).
Correspondingly, effects on pilin function as monitored by pilus production and transfer
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Figure 3.4 Mutations in domains of related pilin subunits have similar effects on
function
Comparison of select mutant phenotypes of related pilin subunits: VirB2A.t., TraAF, and
TrbCRP4. The core pilin sequence for each subunit is shown, including the predicted
transmembrane regions (TM). Related pilin subunits show similarities in predicted structure
with two hydrophobic regions, a long hydrophilic loop, and a shorter cytoplasmic loop. This
summarizes the phenotypes of a subset of point mutations made along the length of VirB2
(Fig.3.1), TraAF (161), and TrbCRP4 (160).
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frequencies have been reported for mutations located near the N-termini of mature TraAF
pilin (161) and N- and C-termini of TrbCRP4 pilin (160) (Fig. 3.4). Together, these data
suggest the hyrodrophilic domain is important for pilin processing but independently of
processing also contributes in unspecified ways to protein function.
My finding that Cys51 and Cys64 residues showed differences in MPB-labeling in
the absence and presence of other VirB proteins suggests the periplasmic domain is
important for machine assembly, possibly by mediating a critical contact(s) with another
VirB subunit(s). In the absence of other VirB proteins, native Cys64 was not labeled in
reactions carried out at pH 7.5, but was labeled at pH 9.5 (Fig. 3.2 C).

These conditions

are expected to favor alkylation of an extramembrane cysteine as well as expose Cys
residues buried in secondary structure. At this elevated pH, maleimides can nonspecifically
label amine groups(162), but the controls showed that Cys-less VirB2 or derivatives with
Cys residues located in the two hydrophobic TM domains did not label. In the absence of
other VirB proteins, therefore, Cys64 is probably buried in secondary structure as opposed
to associating with or embedding into the membrane. In contrast to Cys64, Cys51 was
labeled in a strain lacking other VirB proteins but was not labeled in a strain producing the
other VirB proteins. This mutant pilin might adopt a structure rendering Cys51 inaccessible
only in the context of the assembled VirB machine. Other T4SS subunits may be shielding
MPB-labeling directly or they might indirectly induce a change in the secondary structure of
the VirB2 periplasmic loop. However, because the Cys51-substituted pilin is both less
stable and also confers a Tra-, Pil- phenotype, the observed labeling pattern could reflect an
interaction(s) between the mutant pilin and other VirB subunits that perturbs machine
assembly or function.
The Cys94 substitution constitutes a topological marker for the cytoplasmic loop, as
deduced from its accessibility only in treated cell lysates. Although VirB2 tolerated a L94C
substitution in the central hydrophilic loop, other mutations altering positively-charged
residues in the central loop of TraAF disrupted function (160) (Fig. 3.4), consistent with the
proposed general importance of a positive charge in this cytoplasmic domain for topological
orientation at the IM (163, 164).

Interestingly, however, in other studies of VirB2

summarized in Chapter 7, I introduced epitope tags at various sites in the pilin both to
identify permissive regions and to facilitate pilin and pilus purification. Although insertions
at most sites abolished protein function, a mutant pilin with a FLAG tag (DYKDDDDK)
inserted immediately after residue 85 fully supported both pilus biogenesis and substrate
transfer. This FLAG-tagged pilin will be the subject of further investigations, but at this
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juncture it is intriguing to note that this tag is highly negatively-charged and therefore would
change the overall net charge of the cytoplasmic domain from positive to negative. The fact
that this is a functional protein raises fundamental questions about the requirements for
membrane insertion of this pilin and/or the validity of the model that this pilin integrates into
the membrane during T4SS biogenesis.
Finally, VirB2 generally tolerated Cys substitutions in both hydrophobic domains, as
was also reported for TraAF (161).

However, for both VirB2 and TraAF, mutations of

aromatic (VirB2 F71C; TraAF F50A, F54V, F60V) or charged (TraAF E34A) residues in the
hydrophobic domains disrupt pilus assembly, DNA transfer, or phage attachment. These
mutations could affect membrane insertion of the pilin or packing of hydrophobic helices
during assembly of the pilin into the secretion channel or pilus (161) (Fig. 3.4).

Pilus vs. Secretion Channel
The pilin structural organization or the nature of its homo- or heteromeric contacts in
the two terminal organelles, the secretion channel and T-pilus, are not defined. At least two
lines of evidence suggest that VirB2 pilin assembles not only as the T-pilus but also as a
component of the secretion channel. First, VirB2 was shown to form formaldehydecrosslinkable

contacts

with

translocating

T-DNA

by

use

of

the

transfer

DNA

immunoprecipitation (TrIP) assay (58). Further TrIP studies with various virB mutant strains
also suggested that VirB2 is positioned at the distal portion of the secretion channel,
probably near the OM (58). Second, several “uncoupling” mutations that selectively block
pilus assembly without affecting substrate transfer have been isolated in VirB subunits, e.g.,
VirB6, VirB9, VirB10, and VirB11 (69, 87, 123). The Tra+, Pil- strains harboring these
mutations require synthesis of VirB2 for formation of a functional secretion channel,
confirming the importance of pilin - not the T-pilus - for substrate transfer. Here, I also
isolated the opposite class of “uncoupling” mutation, VirB2 G119C, conferring a Tra-, Pil+
phenotype (Fig. 3.1).

This class of mutations also was isolated in the TrbCRP4 (e.g.,

G114A) (160) and TraAF (e.g., K49A, F50A, F54A, F60V) (161) pilins (Fig. 3.4). The Tra-,
Pil+ “uncoupling” mutation of VirB2 is located in the C-terminal hydrophilic domain (domain
I). In my studies, I determined that Cys94 and Cys119, as well as other Cys substitutions in
domain I, are accessible to MPB-labeling, raising the possibility that one or both of these
hydrophilic domains are exposed within the lumen of the secretion channel. In addition, I
showed that the MPB-labeling patterns of Cys mutants produced in a Tra+, Pil- uncoupling
mutant strain (VirB11. I265T) (87) matched the isogenic, phenotypically wild-type strain, but
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differed appreciably from MPB-labeling patterns of pilins assembled into T-pili (Fig. 3.3).
This is further evidence that VirB2 adopts distinct structural states when assembled as a
component of the secretion channel vs. the T-pilus.

However, deciphering the quaternary

structure of VirB2 in the secretion channel is technically challenging and will require further
studies of VirB2 binding partner interactions and definition of residues or regions in close
contact with translocating substrate.
The T-pilus structure is not yet known, although a structure of the F-pilus has been
presented at ~20 Å by cryoelectron microscopy. This structure yielded dimensions for the
pilus (8 nm) and interior lumen (30 Å) but was insufficient for definition of the pilin packing
geometry (145).

The hydrophobic helices of VirB2 and TraAF likely pack against one

another, resulting in exposure of hydrophilic residues on the surface and interior of the
respective pili (165). To gain insight into the pilin packing geometry, I analyzed the
accessibility of the engineered Cys residues in isolated pili.

My accessibility studies

identified a surface patch, marked partly by MPB-labeling of Cys64 and Cys67 in
hydrophilic domain I (Fig. 3.3 C). Residues 64-69 of VirB2 correspond to residues 17-24 of
TraAF, a region also exposed laterally on the pilus, as shown by bacteriophage binding and
antibody labeling of immunodominant epitopes (161, 166) (Fig. 3.4). For both VirB2 and
TraAF, the surface patch extends into hydrophobic domain II, as shown by labeling of
Cys77 and phage attachment data for a TraAF K28 substitution mutant (161). Cys
substitutions at residues 51, 71 and 117 blocked pilus assembly, and therefore it is possible
that additional residues in domain I of the native protein are also surface-displayed. Cys
substitutions of other hydrophobic residues in domains II and IV were inaccessible to MPB
and are probably buried in pilin-pilin subunit interfaces.
It is interesting to note that hydrophobic domain IV possesses a GG4 dimerization
motif (167, 168) (Fig. 3.5). This motif has been shown to be important for stabilizing
intermolecular helix-helix interactions (169, 170) as well as for stabilizing folding of certain
protein monomers (171-173). In addition, I. Garza in the Christie lab identified a glycine
zipper motif (G-XXX-G-XXX-G) within domain IV (Fig. 3.5). This motif has also been shown
to mediate helix-helix interactions (174).

Conceivably, the GxxxG dimerization motif or the

gylcine zipper mediates formation of domain IV helix – helix interactions among adjacent
VirB2 pilins in the assembled T-pilus.
Cys94 in the hydrophilic central loop did not label and might reside in the interior of
the T-pilus, as also proposed for TraAF in the F pilus (165, 175). Interestingly, TraAF can
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Figure 3.5 Helical wheel representations of VirB2 transmembrane helices, regions II
and IV
Helical wheel patterns shown for VirB2 regions II and IV defined by MPB-labeling shown in
figure 3.1D. Red asterisks denote the predicted GG4 dimerization motif (Gly-X-X-X-Gly) in
VirB2 domain IV. Blue asterisks denote the predicted glycine zipper motif (G-XXX-G-XXXG) identified by I. Garza. This figure is modified from a screen capture of the Java Applet
written by Edward K. O'Neil and Charles M. Grisham (University of Virginia in
Charlottesville, Virginia).
The applet is available at:

http://cti.itc.Virginia.EDU/~cmg/Demo/wheel/wheelApp.html.
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accommodate epitope tags at its C terminus without loss of pilus assembly, and these
epitopes are surface displayed (161, 166, 175).

By contrast, VirB2 G119C was

inaccessible to MPB, suggesting that it is buried in pilus. I have been unable to generate
functional forms of VirB2 pilin with epitope tags inserted at the C terminus probably
because these tags disrupt one or more of the cyclization, folding, or oligomerization
reactions.
The absence of Cys77 labeling upon treatment of intact cells is consistent with
previous findings for this T4SS and the RP4 conjugation system that few T-pili remain
attached to cells (104, 115).

Additionally, at this time there are two general models

describing the mechanism of pilus assembly: i) the T-pilus might assemble from an IM VirBplatform such that the pilus extends across the periplasm and OM, or ii) the T-pilus might
assemble from a VirB platform at the OM in which case no pilus polymer would project
through the periplasm. My inability to detect Cys77 labeling in intact cells, a diagnostic for
T-pilus polymerization, is more consistent with the latter scenario. This is of particular
interest in view of properties that have been ascribed to T-pili and related conjugative pili.
Unlike the F-pilus, which dynamically extends and retracts to mediate mating pair formation
in liquid media, T-pili and related pili are sloughed or broken from the cell surface and
readily form bundles in solution. The released T-pili are thought to promote nonspecific
cell-cell aggregation and formation of mating junctions with target cells(116).

I gained

evidence that VirB2 assembles in the T-pilus in a way that exposes hydrophobic residues in
domain II.

This patch of surface hydrophobicity along the length of the T-pilus could

account for pilus bundling and pilus-mediated aggregation and mating pair formation.
In conclusion, this work provided the first detailed analysis of the inner membrane
topology of VirB2, showed that VirB2 forms distinct structural states as part the secretion
channel and T-pilus, and presented new information about the potential packing
arrangement of VirB2 in the T-pilus.
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Chapter 4: VirB4 and VirB11 ATPases Modulate the Structural State of MembraneIntegrated VirB2 Pilin During Biogenesis of the VirB/D4 Type IV Secretion System

NOTE: This chapter is derived from work that has, for the most part, been published in
2010: “Evidence for VirB4-mediated dislocation of membrane-integrated VirB2 pilins during
biogenesis of the Agrobacterium VirB/VirD4 type IV secretion system.” Journal of
Bacteriology 192(19): 4923-34 PMID: 2065690. I am the primary author on this paper. I
performed all experiments described in this chapter. I have been given permission by the
publisher of Journal of Bacteriology, the American Society for Microbiology, to reproduce
any/all of my manuscript in print or electronically for the purposes of my dissertation
(License Number 2501460079655).
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Introduction
VirB2 pilin is required for elaboration of the T4SS channel and the extracellular Tpilus (25, 128). The VirB2 propilin is processed in two successive steps involving cleavage
of its signal sequence and covalent linkage of the N- and C-terminal residues to form a
cyclic polypeptide, and the mature pilin is inserted into the inner membrane by a secindependent mechanism presumptively as a pool for use in T4SS machine assembly (117).
Little is known about the movement of VirB2 from its inner membrane location to its site of
assembly in the secretion channel and the extracellular T-pilus. A proposed general feature
of T4SS biogenesis is that ATP energy is used to drive pilin extraction and subsequent
polymerization reactions. Although three ATPases, VirB4, VirB11, and VirD4, are required
for elaboration of a functional T4SS channel, only VirB4 and VirB11 are required for T-pilus
assembly (104).
Both VirB4 and VirB11 contain the conserved Walker A nucleoside triphospate
(NTP) binding motif (GxxGxGKT/S) (90, 133). Mutations in the Walker A binding pocket of
VirB4 and VirB11 do not produce T-pili (Pil-) and are unable to transfer substrate (Tra-),
establishing the importance of NTP energy use for T4SS assembly (89, 106, 133). All
T4SSs described to date contain a VirB4-like ATPase, while VirB11-like ATPases are
widespread but not universal (15). Interestingly, conjugative pili, produced by the
Escherichia coli F-like plasmids, actively extend and retract by a process that requires the
VirB4 homolog TraC; yet, these T4SSs lack a VirB11 homolog (15). These observations
prompted a hypothesis that VirB4-like subunits drive early steps associated with
conjugative pilus biogenesis. However, the specific contributions of each of these ATPases
in relation to pilin movement remain to be defined.
The question of how pilin monomers of T4SSs as well as other pilus biogenesis
systems are extracted from the inner membrane to build the pilus is not understood. To
begin to address this question, we asked whether the VirB ATPases induce structural
changes in membrane pilin as monitored with the scanning cysteine accessibility method
(SCAM) (146). SCAM has been used not only to verify predicted membrane protein
topologies but also to study structure–function relationships and the dynamics of protein
function (153, 155, 176-179). In this study, I further defined the requirements for assembly
of the mature, membrane-integrated pilin into the VirB/D4 channel and T-pilus. My findings
support a model that the VirB4 ATPase functions as a pilin dislocase to extract VirB2 from
the inner membrane during machine biogenesis. This function might be a universal feature
of the broadly conserved VirB4 ATPase superfamily.
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Results
In the preceding chapter, I reported differences in MPB-labeling of Cys51, Cys64,
and Cys94 substitution mutations in the presence versus absence of VirB proteins. I
proposed that labeling of Cys94 in the presence of VirB proteins was due to a structural
change in the pilin that exposed the cytoplasmic domain to the periplasm, a change
consistent with membrane extraction. To examine the hypothesis that one or both of the
VirB4 and VirB11 ATPases is responsible for Cys94 labeling, I carried out Cys accessibility
studies with strains engineered to co-produce Cys-substituted pilins together with i) one or
both ATPases or ii) Walker A motif mutants, both in the presence and absence of other VirB
proteins.

VirB4 ATPase Influences MPB-labeling Patterns of Membrane Pilin
I first assayed for MPB-labeling of Cys-substituted pilins in a ΔvirB4 mutant (Fig
4.1A). Interestingly, I found that Cys94 was labeled in a virB4 null mutant complemented
with a plasmid expressing wild-type virB4, but was not labeled in the virB4 null mutant strain
or the isogenic strain producing the VirB4 K439Q Walker A mutant. Previous studies have
shown that the complemented virB4 mutant strains produce abundant levels of native VirB4
or the K439Q mutant and exhibit the expected WT (Tra+, Pil+) and null (Tra-,Pil-)
phenotypes, respectively (133). In addition, the Christie lab has shown that Cys
replacements in cytoplasmic domains of VirB6 (65) and VirB10 (69) are not labeled upon
MPB treatment of whole cells. Strains producing the Cys-substituted VirB6 and VirB10
proteins synthesized native VirB4, excluding the possibility that this ATPase generally
disrupts the inner membrane integrity or otherwise conveys MPB across the cytoplasmic
membrane. I conclude that VirB4 with an intact Walker A motif is required for MPB-labeling
of Cys94-substituted VirB2.
Cys64 also was labeled in a strain producing native VirB4 but not the isogenic
virB4 null mutant strain (Fig. 4.1A). However, in contrast to Cys94, Cys64 was labeled in a
strain producing the VirB4 Walker A mutant, suggesting that accessibility was dependent on
VirB4 production but not on ATP hydrolysis. Importantly, steady-state levels of the VirB2
Cys mutants were unaffected by the absence of native or mutant forms of VirB4.
The above findings prompted a test of whether VirB4 similarly would affect MPBlabeling in the absence of other VirB proteins. As shown in Fig. 4.1B, Cys94 was labeled in
a ΔvirB operon mutant producing only VirB4, but not in the isogenic strain lacking VirB4 or
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Figure 4.1 Effects of VirB4 ATPase on MPB labeling patterns of pilins
(A)

Cys-substituted

pilins

synthesized

in

strain

JK1204

deleted

of

native virB2 and virB4 (nonpolar ΔvirB2, ΔvirB4). (B) Cys-substituted pilins produced in
strain PC1000 (ΔvirB operon mutant). JK1204 and PC1000 were engineered to synthesize
mutant pilins (B2*) with Cys substitutions at the residues indicated at the tops of the blots
alone or with native VirB4 (B4) or a Walker A mutant (KQ) derivative. Panels showing MPB
labeling patterns, VirB2* abundance in the immunoprecipitates. Schematic diagrams of
MPB labeling patterns are presented below the blots for each strain. Thin lines, hydrophilic
loops; gray cylinders, hydrophobic domains; bar, cyclization junction; black-filled circles,
MPB labeled upon treatment of intact cells; gray-filled circles, no MPB labeling. IM, inner
membrane.

Data are presented only for Cys replacements displaying differences in

labeling patterns among the strains analyzed.
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producing the K439Q Walker A mutant. By contrast, Cys64 was not labeled in the ΔvirB
mutant background regardless of the presence of VirB4, showing that VirB4 promotes
MPB-labeling of this periplasmic residue only in the presence of other VirB proteins (Fig.
4.1A). Cys51 was labeled only in the absence of other VirB proteins, and labeling was not
altered by the absence or presence of VirB4 alone (Fig. 4.1B).
Together, these findings indicate that VirB4 exerts an ATP-dependent change in
the accessibility of the region of VirB2 marked by Cys94, and that VirB4 also exerts an
ATP-independent structural change in the region marked by Cys64 but only in the presence
of other VirB proteins.

VirB11 ATPase Influences Membrane Pilin Disposition
I next assayed for effects of the VirB11 ATPase on MPB-labeling of Cys-substituted
pilins. I observed that Cys94 was MPB-labeled in a ΔvirB11 mutant, in agreement with the
above proposal that VirB4 alone (among the T4SS ATPases) is responsible for catalyzing
the structural change required for labeling of this cytoplasmic residue.

I did observe,

however, that production of native VirB11 was required for labeling of Cys64. Cys64 was
not labeled in a ΔvirB11 mutant or an isogenic strain producing a VirB11 Walker A mutant
(Fig. 4.2A). These findings suggest that Cys64 accessibility is dependent on VirB11 ATP
energy binding or hydrolysis activities.
To determine whether the VirB11-dependent effect on MPB-labeling of Cys64
requires the other T4SS proteins, I compared MPB-labeling patterns for VirB2 synthesized
in a ΔvirB operon mutant or this strain engineered to co-produce only native VirB11 or the
VirB11 K175Q Walker A derivative (Fig. 4.2 B). Cys64 was not labeled in any of these
strains, suggesting that VirB11 requires at least one other VirB protein to catalyze a
structural change necessary for Cys64 labeling.

VirB4 and VirB11 Act Synergistically to Direct Structural Differences in MembraneAssociated Pilin
In the above studies, I assayed for effects of each ATPase on pilin structure as
monitored by SCAM. Next, I sought to determine whether the two ATPases act together to
induce structural changes in the cell-associated pilin. To examine this possibility, a ΔvirB
operon strain lacking other VirB proteins was engineered to coproduce the VirB2 Cys
mutants with VirB4 and VirB11.
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Figure 4.2 Effects of VirB11 ATPase on MPB labeling patterns
Effects of VirB11 ATPase synthesis on MPB labeling patterns of pilins. (A) Cys-substituted
pilins synthesized in strain PC1211 (nonpolar ΔvirB2, ΔvirB11). (B and C) Cys-substituted
pilins produced in strain PC1000 (ΔvirB operon mutant). PC1211 and PC1000 were
engineered to synthesize mutant pilins (B2*) with Cys substitutions at the residues indicated
at the tops of the blots alone or together with VirB11 (B11), a VirB11 Walker A mutant (KQ)
derivative, or both native VirB11 and VirB4. Panels showing MPB labeling patterns, VirB2*
abundance in the immunoprecipitates, and schematic representations of the labeling
patterns are as described in the Fig. 4.1 legend. Data are presented only for Cys
replacements displaying differences in labeling patterns among the strains analyzed.
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Interestingly, both Cys64 and Cys94 were MPB-labeled when the mutant pilins were cosynthesized with VirB4 and VirB11 but no other VirB proteins (Fig. 4.2C). Labeling profiles
of these residues were therefore identical in strains producing just the VirB ATPases or
strains producing all of the VirB proteins (see Fig. 4.1A, 4.2A). These findings indicate that
VirB4 and VirB11 together coordinate structural changes in pilin necessary for labeling of
Cys64 and Cys94, even in the absence of other VirB subunits.

However, it is also

noteworthy that Cys51 was labeled in the absence of VirB proteins, and synthesis of VirB4
and VirB11 in this background did not alter the labeling pattern (Fig. 4.2C). Synthesis of
other VirB proteins thus appears to be necessary for a structural change in the pilin to
render Cys51 inaccessible to MPB-labeling.

VirB2 and VirB4 Form a Precipitable Complex
The above findings suggest that VirB2 interacts with one or both of the VirB
ATPases at the inner membrane. I assayed for complex formation between VirB2 and both
VirB ATPases by immunoprecipitation. To stabilize possible interactions, I treated isolated
membranes with the crosslinker dithiobis succidimidyl propionate (DSP) prior to
solubilization with RIPA buffer (Containing detergents - 0.1% SDS, 0.5% sodium
deoxycholate, 1% NP-40). As shown in Fig. 4.3, anti-VirB2 antibodies coprecipitated VirB2
and VirB4 from membrane extracts of strains producing both proteins both in the presence
and absence of other VirB proteins. VirB2 also formed a precipitable complex with the VirB4
Walker A motif mutant, suggesting that ATP binding/hydrolysis is not required for this
interaction. In control experiments, anti-VirB2 antibodies did not precipitate VirB4 from
extracts of a ΔvirB2 mutant, nor was an immunoreactive species the molecular size of VirB4
(87-kDa) precipitated from a ΔvirB4 mutant. I attempted but was unable to detect VirB11 in
immunoprecipitates recovered with anti-VirB2 antibodies from membrane extracts of
VirB11-producing strains. VirB11 thus might exert an effect on VirB2 structure through
transient or weak affinity interactions, either directly with the pilin or indirectly through a
VirB4 contact. Together, these results suggest that VirB2 does interact in an energy
independent fashion with VirB4. Although other VirB proteins are not required for VirB2VirB4 complex formation, my present findings do not exclude the possibility that another
non-VirB protein could mediate this interaction.

66

Figure 4.3 VirB protein complexes
VirB protein complexes isolated from detergent-solubilized membrane extracts by
immunoprecipitation
PC1004; ΔvirB2,

(IP)

with

anti-VirB2

JK1002; ΔvirBoperon,

or

anti-VirB4

PC1000; ΔvirB11,

antiserum.
PC1011

Strains: ΔvirB4,
(engineered

to

synthesize the VirB proteins indicated in addition to those produced from the Ti plasmid).
B2, VirB2; B4, VirB4; B4KQ, VirB4K439Q; B11, VirB11. Anti-VirB2 (ΔB2) and anti-VirB4
(ΔB4) antibodies were used for immunoprecipitation (IP) (left) and development of
immunoblots (Blot Dev) (right).
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VirB4 Domains Exposed in Periplasm
If VirB4 interacts directly with VirB2, it would need to interact with the inner
membrane. In early studies, the Christie lab supplied evidence that VirB4 tightly associates
with the membrane (180). By PhoA fusion reporter and proteinase K digestion analyses,
evidence was also presented for an extracytoplasmic domain(s) of VirB4 (105). Native
VirB4 possesses 9 Cys residues, and one of these, Cys57, is predicted to reside in the
periplasm on the basis of the earlier reporter fusion studies (105).

Interestingly, I found

that VirB4 was MPB-labeled both in the presence and absence of other VirB proteins (Fig.
4.4). Moreover, a Walker A motif, mutant form of VirB4 was also MPB-labeled, suggesting
that VirB4 spans the inner membrane independently of its catalytic activity. I also detected
increased labeling in cells treated with MPB during sonication, consistent with labeling of
additional Cys residues located in the cytoplasmic domain. In future studies, it should be
feasible to localize the region of VirB4 that interacts with VirB2 through a combination of
MPB labeling studies to refine the VirB4 topology model and disulfide crosslinking studies
with Cys-substituted binding partners.
VirB4-Mediated Release of Membrane Pilin
To further evaluate a model that VirB4 interacts with VirB2 pilin to catalyze its
dislocation from the inner membrane, I assayed for VirB4-dependent release of VirB2
during osmotic shock. I detected appreciably more VirB2 in the shockate of strains
producing native VirB4 than strains lacking this ATPase. Additionally, VirB4 alone among
the VirB proteins sufficed for release of VirB2 into the shockate fraction (Fig. 4.5A). A VirB4
Walker A mutant did not mediate release of VirB2 into the shockate fraction, consistent with
the notion that VirB4 catalyzes VirB2 dislocation by an ATP-dependent mechanism.
Furthermore, VirB2 was barely detectable in the shockates of strains producing VirB11 and
VirB2 alone, further demonstrating VirB11 does not liberate VirB2 from the membrane.
To confirm that osmotic shock did not result in massive cell lysis or that VirB4 did
not somehow disrupt the integrity of the inner membrane, shockates were analyzed for the
presence of periplasmic (ChvE) and cytoplasmic (VirE2) markers (Fig. 4.5A), outer
membrane markers (VirB7) and inner membrane markers (VirB10, VirB11) (Fig. 4.5B). The
VirE2 secretion substrate was present in low amounts in the shockate and levels were
independent of the presence of the VirB T4SS as shown previously (47, 181). ChvE was
also present at low levels in the shockate fractions of strains producing or lacking VirB4.
Inner membrane markers, VirB10 and VirB11 (69, 90), were readily detectable in the cell
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Figure 4.4 MPB labeling of VirB4
MPB labeling patterns of native cysteine residues in ATPase VirB4. VirB4 synthesized in
strain PC1004 (nonpolar ΔvirB4). Wild type VirB2 pilin (B2) and VirB4 or VirB4 Walker A
mutant (KQ) derivative produced in strain PC1000 (ΔvirB operon mutant). Panels showing
MPB labeling patterns in whole cells and cell lysates following sonication and VirB4
abundance in the immunoprecipitates.
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Figure 4.5 VirB4-mediated release of VirB2 upon osmotic sock treatment
Osmotic shock treatment, showing the presence of proteins indicated at the right in
material released by osmotic shock (OS) or in the cell pellet (CP) obtained from
centrifugation of shocked cells. (A) Detection of VirB2, periplasmic ChvE, and cytoplasmic
VirE2. (B) Detection of outer membrane protein VirB7 and inner membrane proteins VirB10
and VirB11. Strains: ΔvirB2 ΔvirB4, JK1204; ΔvirB, PC1000; WT, A348 (engineered to
synthesize the VirB proteins listed in addition to those produced from the Ti plasmid). B2,
VirB2; B4, VirB4; B4KQ, VirB4K439Q; B11, VirB11; B11KQ, VirB11K175
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pellets, but not in the shockate fractions.

Finally, VirB7 levels were comparable in

shockates from all strains. The shockate fractions thus are comprised predominantly of
periplasmic material and OM fragments. These findings further support the proposal that
VirB4 catalyzes release of VirB2 pilin from the inner membrane.

VirB/D4 Type IV Secretion System Assembly Pathway
Together, results of my studies indicate that VirB4 catalyzes dislocation of the VirB2
pilin early during biogenesis of this T4SS. VirB11 also coordinates with VirB4 to coordinate
a structural change(s) in the pilin (Fig. 4.6). Summarizing the proposed steps of pilin
maturation: i) VirB11 functions in concert with VirB4 to induce a structural change in
membrane-integrated pilin (as shown by labeling of Cys64), ii) VirB4 then liberates VirB2
from the membrane (as shown by Cys94 labeling), and iii) the pilin makes further contacts
with remaining VirB proteins to form the secretion channel or T-pilus (resulting in blocking of
Cys51 labeling).
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Fig 4.6 Schematic summarizing effects of VirB4, VirB11, and other VirB subunits on
MPB labeling patterns
MPB labeling patterns are presented. Thin lines, hydrophilic loops; gray cylinders,
hydrophobic domains; bar, cyclization junction; black-filled circles, MPB labeled upon
treatment of intact cells; gray-filled circles, no MPB labeling. IM, inner membrane.
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Discussion
Biogenesis of the VirB/D4 T4SS requires maturation of VirB2 pilin in several steps.
The early reactions (signal recognition and cleavage, head-to-tail cyclization, membrane
insertion) occur independently of other VirB subunits, whereas subsequent reactions
(membrane extraction, incorporation into a functional secretion channel, T-pilus
polymerization) require the remaining 10 VirB subunits. To begin defining the mechanistic
details underlying these latter virB-dependent reactions, I used SCAM to monitor changes
in VirB2 pilin. Here, SCAM studies identified effects of the VirB4 and VirB11 ATPases on
the pilin structural state. Complementary coimmunoprecipitation and osmotic shock data
further supported a model that VirB4 catalyzes dislocation of mature pilin from the IM
through direct protein-protein contact and by a mechanism requiring an intact Walker A
motif. VirB11 ATPase also contributes to the pilin structural organization, although probably
indirectly through a functional interaction with VirB4.
Early studies established the importance of the VirB4 and VirB11 ATPases for
assembly of both the secretion channel and T pilus (87, 89, 112, 133, 180), but how these
subunits convert chemical energy derived from ATP hydrolysis into mechanical energy for
machine biogenesis has remained poorly understood. Here, I showed that VirB4 induces a
structural change in VirB2 resulting in MPB accessibility of a Cys substitution located in a
cytoplasmic loop (fig 4.1). Importantly, Cys residues located in other cytoplasmic protein
domains did not label in any VirB4 producing strains, implying that MPB inner membrane
permeability was unaffected by the presence of this ATPase. Thus, I suggest that exposure
of Cys94 is the result of VirB4 catalyzing extraction of pilin subunits from the inner
membrane into the periplasm. VirB4-mediated Cys94 accessibility and VirB2 release into
the shockate fraction required an intact Walker A motif and occurred independently of other
VirB proteins, indicating that VirB4 alone catalyzes the observed structural changes by a
reaction dependent on ATP binding or hydrolysis. In this study, I examined the Walker A
box mutation at K439Q, which has previously been shown to be defective for pilus
biogenesis and substrate transfer (106, 133), with similar mutations in VirB4 homologs
(TrbERP4 and TrwKR388) blocking protein function. Interestingly, however, a previous study
reported that a different Walker A variant of VirB4At (K439R) from that used here blocked
substrate transfer but still elaborated T-pili albeit at low levels (122). The K439R Walker A
mutation, which has not been biochemically characterized, is less disruptive structurally
than the K439Q mutation and maintains the charge of the binding pocket. Thus, the mutant
protein might hydrolyze ATP at levels sufficient for some pilus production. Coupled with
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evidence that VirB4 forms a precipitable complex with VirB2 (Fig 4.3) presumably through
contacts with VirB4 in the transmembrane region and/or periplasm (Fig 4.4 and (105)), our
findings support a working model that VirB4 functions as a dislocation motor to catalyze
extraction of pilin subunits from the IM during T4SS biogenesis.
As noted earlier, VirB4-like subunits are signatures for all bacterial and archaeal
T4SS (15), and for the F-like T4SS’s VirB4-like subunits are the only ATPases required for
extracellular elaboration of pilin (182-185).

Earlier studies have shown that there are

ATPases capable of membrane protein extraction/dislocation (186, 187). The VirB4
ATPases possess physical properties consistent with another well-characterized dislocase,
E. coli FtsH (186). A. tumefaciens VirB4 associates integrally with the IM via one or two
membrane-spanning domains (Fig 4.4 and (105)).

Other VirB4-like ATPases such as

TraCF, TraBpKM101 and TrwKR388 also associate with the membrane, although soluble forms
of native or mutant forms of these proteins also exist (110, 182, 188). A C-terminal domain
of VirB4 also was shown to possess limited sequence homology with the TrwB

R388

substrate receptor (108), and on this basis the VirB4 C-terminal domain was predicted to
assemble as homohexameric rings. In agreement, VirB4 was found to form oilgomers under
native conditions consistent with the size of a hexamer (122). Moreover, hexameric forms
of both TraBpKM101 and TrwKR388 were detected upon size fractionation of purified forms of
these proteins (109, 110). Hexameric but not other oligomeric forms of these ATPases,
e.g., dimers, were shown to hydrolyze ATP (110). Lastly, VirB4-like subunits have been
found to play a critical role in key protein interactions of the T4SSs (110, 122, 189).
Specifically, VirB4At has been shown to interact with ATPases VirB11 and VirD4 (45),
bitopic proteins VirB8 (122, 190) and VirB10 (190), and the inner membrane protein VirB3
(66, 189). Taken together, these attributes are consistent with known protein
dislocase/protease FtsH and the GspE ATPases predicted to function as pilin dislocases in
type IV pilus systems (186, 187, 191, 192). GspE ATPases undergo dynamic changes in
structure following ATP hydrolysis (191). While VirB11 is related in sequence to the GspE
ATPases, I supplied evidence that VirB4 functions as a VirB2 dislocase. Yet, I also showed
that VirB11 coordinates with VirB4 to effect a change in pilin structural organization, as
monitored by labeling of Cys64 (Fig. 4.2). Previous work has shown that these two
ATPases interact (45) and therefore it is possible that VirB11 acts through VirB4 to induce a
structural modification in the pilin periplasmic domain required for subsequent contacts with
other assembly factors in the periplasm or at the outer membrane (see below).
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Interactions between the VirB2 pilin and the VirB ATPases have not been previously
reported. Here, I supplied evidence for complex formation between VirB2 and VirB4 by
coimmunoprecipitation (Fig. 4.3). Furthermore, I showed that VirB4 is MPB-labeled upon
treatment of whole cells (Fig 4.4) indicating that at least a portion of the protein is exposed
to the periplasm, in agreement with previous studies (105). Presumably, the membranespanning or periplasmic domains of VirB4 interact with the membrane-integrated pilin, and
further studies in the Christie lab are evaluating this possibility. Small integral membrane
proteins, often homologs/orthologs of VirB2At pilin, are commonly found upstream of virB4
loci (15). Thus, complex formation and/or interaction between VirB4-like ATPases and
associated pilin-like subunits may represent a general characteristic of T4SSs.
I propose that a VirB4 dislocase directs an early step in T4SS machine biogenesis.
VirB4 forms stabilizing interactions with other inner membrane subunits including VirB3 and
VirB8 (66, 122, 189, 190). Furthermore, in agreement with our findings, VirB4 was shown
to be required for assembly of a cell-associated complex of VirB2 and the pilus-associated
protein VirB5 (122). Although no other VirB2 binding partners have been identified besides
VirB4 (this study, Fig. 4.4) and VirB5 (122), a VirB5 interaction with the periplasmic domain
of VirB8 was identified (122). In view of this emerging protein-protein interaction network, a
model can be proposed wherein VirB11 modulates VirB4 which then functions in the
context of a VirB3/VirB4/VirB8 ternary complex to dislocate VirB2.

The membrane-

extracted VirB2 then interacts with VirB5 to mediate binding with VirB8 (77), which has
been postulated to function as an assembly center for building of the VirB/D4 T4SS at
specific sites on the cell envelope. Presumably this network of interactions involving VirB2,
VirB3, VirB4, VirB5, and VirB8 occurs within the VirB7/VirB9/VirB10 core complex allowing
for further protein interactions necessary for pilin subunits to form the distal portion of the
secretion channel (58, 87) and polymerize into the T-pilus (Fig 4.7).
My findings add new mechanistic detail to the VirB/VirD4 T4SS biogenesis pathway,
and raise the possibility that VirB4 family members function generally as T4SS-specific
membrane protein dislocases.

Overall, a mechanistic understanding of the T-pilus

assembly pathway will provide targets for development of inhibitory compounds that
specifically block individual steps of pilus biogenesis.

Information about this system also

may guide studies exploring the assembly pathways of phylogenetically distinct pilus
systems.
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Fig 4.7 Model of T-pilus biogenesis pathway
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown
according to their proposed localization and interactions. Black arrows indicate the path of
the pilin. Biogenesis pathway: i) VirB2 inserts into the inner membrane where it is cleaved
and cyclized, ii) it then interacts directly with VirB4, iii) VirB11 interacts with VirB4 leading to
a change in pilin structure, iv) VirB4 extracts VirB2 from the inner membrane, and, finally, v)
pilin subunits are shunted through the T4SS core complex and incorporated in the secretion
channel and T-pilus. P: periplasm; IM: inner membrane; OM: outer membrane.
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Chapter 5: The Role of VirB10 Domains in T-pilus Biogenesis and Type IV Substrate
Secretion

NOTE: This chapter is derived from work that has been published in 2009: “Agrobacterium
VirB10 domain requirements for type IV secretion and T pilus biogenesis.” Molecular
Microbiology 71(3): 779-794 (doi: 0.1111/j.1365-2958.2008.06565.x). I am one of the coprimary authors on this paper. Experiments performed by the other authors, Dr. Simon
Jakubowski, Vidhya Krishnamoorthy, or Isaac Garza, are indicated in the figure legend or
text. I have been given permission by the publisher of Molecular Microbiology, John Wiley
and Sons, to reproduce any/all of my manuscript in print or electronically for the purposes of
my dissertation (License Number 2501460079655). Crystal structure images were modeled
in

PyMOL.

An

educational-use

program

copy

of

PyMOL

was

obtained

from

http://pymol.org/ep, which states that images may be used for thesis/dissertation projects.
All

structural

coordinates

were

obtained

from

the

RCSB

protein

data

base

http://www.rcsb.org/pdb and individual identification numbers and specific references are
included in the figure legends.
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Introduction
Homologs of the Agrobacterium tumefaciens VirB7, VirB8, VirB9, and VirB10
subunits are present in nearly all Type IV secretion systems (T4SSs) of Gram-negative
bacteria (39, 70). A number of biochemical and ultrastructural lines of evidence indicate
that these subunits assemble as ‘core’ subcomplexes required for building functional
translocation systems (67, 68, 71-73). These ‘core’ subunits are required for both substrate
transfer and T–pilus biogenesis in A. tumefaciens (104, 128). Studies of the VirB10At
subunit have shown that it forms stabilizing interactions with the VirB7 lipoprotein and the
outer-membrane-associated VirB9 (71, 72, 193).

Additionally, VirB10 was shown to

undergo a structural transition in response to ATP utilization by the VirD4 and VirB11 ATPbinding subunits, as monitored by protease susceptibility (83). This structural change is
important for productive complex formation with VirB7 and VirB9, and it allows for transfer
of DNA substrates through the distal portion of the secretion channel (58, 123).
A core channel complex composesd of homologs of VirB7, VirB9 and VirB10 from
the pKM101 T4SS was recently solved by cryo-EM and X-ray crystal structure analysis (67,
68). This 1.05 MDa hollow complex spans both the inner and outer membranes, forming a
cylindrical structure composed of 14 copies of each subunit.

A striking feature of the

structure is that the VirB10-like TraF subunit appears to span the entire cell envelope. An
N-terminal transmembrane (TM) domain anchors the protein to the inner membrane. The
protein then extends across the periplasm, in part via a Pro-rich domain termed the PRR
(69). Part of VirB10-like TraF then extends across the outer membrane pore and may be
able to function as a gate or regulator of secretion and/or T-pilus elaboration. This proposed
transenvelope topology is unique among bacterial proteins and warrants experimental
confirmation as well as further characterization of functional significance. That VirB10-like
subunits function as transenvelope bridging proteins is supported by evidence for
interactions between VirB10-like proteins from A. tumefaciens and plasmids R27 and R388
with at least one ATPase subunit at the inner membrane (45, 107, 194, 195). A.
tumefaciens VirB10 was shown to form complexes with the three ATPases -VirB4, VirB11,
and VirD4 of the VirB/VirD4 system (45, 83, 107, 196). As noted above, at or near the
outer membrane, VirB10 also interacts with lipoprotein VirB7 and VirB9 (45, 71, 72, 74,
137, 193, 197, 198).
In light of these findings, VirB10 is thought to function as both a ‘structural scaffold’
for the core channel, as well as an energy sensor/transducer, possibly gating the outer
membrane channel complex during substrate translocation and T-pillus assembly. Similar
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to VirB10, TonB from Escherichia coli senses energy via the proton motive force through
complex formation with the inner membrane proteins ExbB and ExbD (199-202). VirB10
and TonB share similar structural features containing a short N-terminal cytoplasmic
domain, a transmembrane region (69), a proline rich region, and a C-terminal periplasmic
domain. In one model, TonB was proposed to facilitate active transport by ‘shuttling’ from
the inner membrane to the outer membrane in response to energy (203). More recent
findings suggest that TonB is stably anchored to the inner membrane (200), as we have
shown is the case for VirB10 (69). How the VirB10 and TonB energy sensors transduce
inner membrane energy to mediate outer membrane translocation remains to be
determined.
The C-terminal domains of two VirB10 homologs, Helicobacter pylori ComB10 and
pKM101 TraF, have been solved by X-ray crystallography (68, 73). These structures both
present as modified β-barrels with inherent flexible regions. One main feature is the
antennae projection (AP), composed of alpha helical regions designated α2,α3, which
extends out from the top of the β-barrel. In the TraF structure, solved as a large complex of
14 copies of VirB10-like TraF, VirB7-like TraN and VirB9-like TraO, the AP domains form a
pore that was postulated to span the outer membrane (68).

A second region that I have

named the ‘bridging’ domain (BD) connects the AP via a flexible section to the core barrel
structure. A third region, designated α1 for ComB10 (73) and αn1 for TraF (68), extends out
to the side of the β-barrel region. In the TraN/O/F structure, the αn1 helix of one TraF
monomer forms contacts with β-barrel domains of neighboring TraF monomers to stabilize
the core complex (68).

The β-barrel contains a large grooved ‘pocket’ along its side

together with a flexible flap domain and a conserved XDLDF motif at its base (73). The
ComB and TraF structures likely represent structural paradigms for VirB10-like proteins, as
deduced from the overall extensive primary and secondary structural conservation of the
family members (30).
In the previous chapters of this thesis, I presented results of my studies defining
early steps in the assembly of the VirB2 pilin into the T4SS channel and T-pilus. Following
integration and processing of the pro-pilin, VirB4 and VirB11 work together to mediate pilin
structural changes resulting in membrane dislocation and formation of subsequent
interactions in the assembly pathway. In view of my model that upon dislocation from the
membrane the pilin enters the VirB7/VirB9/VirB10 core chamber, and the current structural
information indicating that VirB10 might span both cell membranes (67), I hypothesized that
VirB10 contributes to the movement of pilin monomers to their final destinations in the
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terminal organelles. The polymerization of pilin monomers into T-pili is easily monitored by
assaying for surface-exposed VirB2 and assembly of high-molecular-weight VirB2
complexes. By contrast, at this time little is known about the disposition of VirB2 in the
secretion channel and no specific assays are available to monitor pilin incorporation into the
channel. Consequently, here I focused my mutational studies on defining the contributions
of VirB10 motifs or domains to T-pilus assembly.
I characterized a number of VirB10 mutations generated by V. Krishnamoorthy and
I. Garza with the goal of defining the importance of conserved motifs and domains to T-pilus
assembly.

I collaborated with these lab members and S. Jakubowski, who together

analyzed effects of the mutations on protein stability and substrate transfer. A principal
finding of interest reported in the publication of this collaborative effort was the discovery of
mutations that permit substrate transfer while blocking assembly of T-pili. These so-called
‘uncoupling’ mutations were isolated in the two regions of VirB10 implicated in spanning the
membranes – the N-terminal TM domain and the AP. Our findings support a model in
which VirB10 can selectively regulate formation of the extracellular T-pilus or the secretion
channel. In the next section, I highlight my contributions to this larger study.
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Results
The mutations (see Fig. 5,1) I. Garza and V. Krishnamoorthy created along the
length of VirB10 included: i) two residue (Ala-Cys) insertions at 5-residue intervals along the
N-terminal region, ii) Cys substitutions within the proline-rich region (PRR), α1 lever arm,
and β-barrel, and iii) deletion of the N-terminus, TM, and/or PRR regions. V.
Krishnamoorthy also constructed several deletion mutations within the conserved Cterminal domain based on structural information for the VirB10 homologs crystallography
(68, 73). Two regions predicted to be important for function were the antennae projection
(AP) which extends from the top of the β-barrel and the ‘bridging domain’ that connects the
AP to the barrel structure (based on the TraF structure) (68). I characterized these
mutations, looking for defects in T-pilus production, whereas other lab members assayed
for effects on protein stability and substrate transfer.

Mutations Within the N-Terminus of VirB10 Selectively Disrupt T-pilus Biogenesis
VirB10 has been shown to directly or indirectly interact with all of the ATPases in the
VirB/VirD4 T4SS (45, 83, 107, 196). These ATPases are primarily located at the
cytoplasmic face of the inner membrane (90, 105, 159). Both the N-terminal cytoplasmic
and TM region of VirB10 are predicted to play a critical role in mediating those interactions.
The Christie lab predicted that the insertion mutations in these regions should impact
substrate transfer as a result of disrupted contacts with one or more of the ATPases. In
order to test this hypothesis, I assayed strains producing the N-terminal deletion and 2residue insertion (i2) mutant proteins for effects on T-DNA transfer and T-pilus production.
The i2 mutations along the cytoplasmic domain did not affect protein function, as
monitored by substrate transfer and T-pilus biogenesis (Fig. 5.2) (69). However, a partial
deletion (Δ2-18) completely blocked pilus production but still allowed for a low level of TDNA transfer, showing the importance of the extreme N terminus of VirB10 particularly for
pilus production (Fig. 5.2). A longer deletion of the cytoplasmic and TM domains (Δ2-46)
was nonfunctional (Fig. 5.2) (69). This mutant protein was delivered to the periplasm by
fusion to the VirB5 signal sequence and although it accumulated at abundant levels, it was
nonfunctional possibly because it failed to form a complex with the VirD4 ATPase
[experiment performed by Vidyha Krishnamoothy, (69)]. Besides the importance of the
extreme N terminus for pilus production, I determined that i2 mutations at positions 35, 40,
and 45 in the TM domain significantly reduced or abolished pilus production without
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Figure 5.1 Schematic of VirB10 domains and mutations
A) Cartoon of VirB10 domains with C-terminal β-barrel domain depicted by crystal structure
from VirB10 homologue TraFpKM101 (68) and associated structural features (67, 204). B)
Top: The various domains of VirB10 and their locations with residue numbers above are
depicted. Domain abbreviations: Cyto, cytoplasmic domain; TM, transmembrane helix,
PRR, proline-rich region. Ala, Cys (i2, AC; black dots) insertion mutations were engineered
at five-residue intervals in the N-terminal 50 residues. Cys substitution mutations in the
remainder of the protein are listed at top; Ser substitutions for the two endogenous Cys
residues, Cys190 and Cys206 (underlined), also were characterized. Bottom: Deletion
mutations of various domains with deleted residues indicated; alternative designations used
in the text for some deletion mutations are listed above the corresponding line. The ∆N46
and ∆N150 fragments were exported to the periplasm by fusion to the signal sequence of
VirB5 (B5ss). ∆AP, deletion of the antennae projection (see (67, 68, 73)). Deletion
mutations were constructed by V. Krishnamoorthy. Cysteine substitutions and two residue
insertions were constructed by I. Garza. Shown is the TraF β-barrel modeled with coordinates

from

pKM101

core

outer

(DOI:10.2210/pdb3jqo/pdb) (67, 68) using

membrane

complex

X-ray

structure
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figure.
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Figure 5.2 Phenotypes of N-terminal insertion and deletion mutations
Effects

of

mutations

on

T-DNA

transfer

as

monitored

by

virulence

on

wounded Kalanchoe leaves (− avirulent, +++ WT virulence) and effects of mutations on Tpilus production. Top-to-bottom: colony immunoblots developed with anti-VirB2 antibodies
showing presence of surface-exposed pilin protein (B2 surface); extracellular shear fraction
subjected to ultracentrifugation, gel electrophoresis and immunoblot development with antiVirB2 antibodies revealing presence of high-molecular-weight T-pilus (B2 shear); total
cellular material subjected to gel electrophoresis and blot development with anti-VirB2
antibodies revealing total cellular levels of the protein. Strains: WT, wild-type A348; ∆B10,
non-polar virB10 strain PC1010; ∆18, PC1010 producing VirB10∆1–18; ∆46, PC1010
producing VirB10∆1–46 fused to the VirB5 signal sequence for export of the C-terminal
fragment to the periplasm; 5–50, PC1010 producing i2 (Ala–Cys) insertion mutations at the
residue indicated. DNA transfer experiments were performed by I. Garza for i2 insertions
and Cys substitution mutations and V. Krishnamoorthy for deletion mutations.
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influencing DNA substrate transfer (Fig. 5.2). None of the deletions or insertions impacted
the stability of cell-associated VirB2.
Contributions of the Proline Rich Region and β-barrel domain to VirB10 Function
Deletion and Cys-substitution mutations were introduced along the PRR and βbarrel domains of VirB10. These were extensively characterized and the results published
(69). Here, I will summarize my contributions to this larger study focusing on testing the
effects of the various mutations on pilus biogenesis.
First, with respect to mutations in the VirB10 PRR domain, the most informative
mutations were partial or full deletions of this domain. These abolished all protein function,
including pilus biogenesis (Fig. 5-3), and they also abolished the capacity of VirB10 to form
a precipitable complex with the outer membrane-associated VirB7 and VirB9 proteins
(experiments performed by S. Jakubowski, (69)).

In earlier studies, it was shown that

Proline-rich regions (PRRs) of proteins adopt extended structures and also mediate proteinprotein interactions (205). The VirB10 PRR might, therefore, adopt an extended structure
necessary for a productive and stable interaction with the outer membrane core subunits
(67, 68). In support of this idea, an N-terminal fragment of VirB10 composed of the
cytoplasmic domain, TM domain and PRR (Δ150-377) also was nonfunctional with respect
to transfer substrate and T-pilus production (Fig. 5.3). This mutant protein failed to interact
with VirB7 or VirB9 (S. Jakubowski, (69)). Conversely, a C-terminal β-barrel fragment (Δ1150) delivered to the periplasm by fusion to the VirB5 signal sequence was defective for
both substrate transfer and T-pilus production (Fig. 5.3); however, it did show complex
formation with VirB7 and VirB9 [S. Jakubowski; (69)]. Together, these results establish the
importance of the PRR most likely for enabling VirB10 to extend across the periplasm.
With respect to the β-barrel domain, mutations that abolished substrate transfer also
abolished pilus biogenesis (Fig. 5.4). In general, these were Cys substitutions of residues
that are conserved among VirB10 homologs.

These mutations might affect contacts

between adjacent β-barrel domains, or β-barrel domain contacts with other VirB channel
subunits, but further studies are needed to examine these possibilities.

The Antennae Projection Selectively Contributes to T-pilus Assembly
The TraF β-barrel domain possesses two extensions, the α1 lever arm and the
antennae projection (AP). The AP is a helix-loop-helix that potentially spans the outer
membrane (68) (Fig. 1.3B). In VirB10, the corresponding AP is predicted to span residues
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Figure 5.3 Phenotypes of PRR deletions and substitution mutations.
Effects of mutations on T-DNA transfer as monitored by virulence on wounded
Kalanchoe leaves (− avirulent, +++ WT virulence) and effects of mutations on T-pilus
production. Extracellular pilin and T pilus, and total cellular pilin and VirB10 derivatives were
detected as described in Fig. 5.1 legend. Strains: WT, wild-type A348; ∆B10, nonpolar virB10 strain PC1010; isogenic PC1010 producing the following PRR mutants –∆70–
92, ∆93–114, ∆70–114, PRR internal deletion mutants; ∆N150, residues 150–377
containing the β-barrel domain exported to the periplasm by fusion to the VirB5 signal
sequence; ∆181–377, residues 1–180 containing the cytoplasmic, TM, PRR and linker
domains; Cys substitution mutants as listed. DNA transfer level experiments were
performed by I. Garza, V. Krishnamoorthy and S. Jakubowski.
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282-335. Strikingly, partial deletions of the AP (here ΔAP denotes deletion of TraF based
alpha 3 and linker region; Δ308-320, Δ323-337, Δ303-337) and a couple of Cyssubstitutions in the AP did not affect DNA transfer (Fig. 5.5A and see (69)), suggesting that
the AP region is dispensable for DNA transfer. Additionally, TraF also has a predicted
flexible section I have denoted as the ‘bridging’ domain (BD). The BD connects the AP to
the β-barrel. Interestingly, a BD deletion mutation (Δ268-287) diminished but did not abolish
substrate transfer (Fig. 5.4A), suggesting that the BD contributes to but is not essential for
substrate transfer.
Although the mutational analyses established that both the AP and BD were found
to be dispensable for substrate transfer, my further studies showed that both regions are
vital for T-pilus biogenesis (Fig. 5.4).

Strains synthesizing the ΔAP and ΔBD mutant

proteins possessed low levels of extracellular VirB2, as monitored by the colony blot and Tpilus shear assays (Fig. 5.4A). I also analyzed the extracellular fractions by sucrose density
gradient centrifugation. Interestingly, whereas pili isolated from the wild-type strain
distribute across the gradient as a broad peak, VirB2 from the ΔAP and ΔBD mutant strains
distributed predominantly in the low and high density sucrose fractions (Fig. 5.5A). These
findings suggest that the mutant strains released VirB2 to the cell surface, but as
monomers or short polymers or aggregates as opposed to intact pilus fibers.
To determine if this observed phenotype is restricted to the AP and BD deletion
mutations, I subjected extracellular fractions from other mutant strains (e.g., i2.35, i2.45,
N218C) whose phenotypes resembled those of the ΔAP and ΔBD mutants, namely,
reduced accumulation of extracellular VirB2 but Tra+ (see Figs. 5.2 and 5.4) to sucrose
density fractionation. All three mutants demonstrated a disperse profile of VirB2 consistent
with wild-type pilus assembly; representative data are shown for pili obtained from the
N218C mutant strain (Fig. 5.5A).
I further analyzed the extracellular material from AP deletion using an analytical gel
filtration (AGF) column. Due to the low production of VirB2 in the AP deletion mutant, ten
times the amount of extracellular material relative to wild type was subjected to AGF. VirB2
from wild-type cells partitioned in a size range consistent with high molecular weight T-pili
(>100kDa) (fig. 5.5B). By contrast, the majority of extracellular VirB2 from the ΔAP mutant
was present in the lower molecular weight species (<10kDa) (Fig. 5.5B). Taken together,
these results indicate that the AP and the BD are critical for T-pilus polymerization.
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Figure 5.4 Phenotypes of β-barrel deletions and substitution mutations.
A)

Effects

of

mutations

on

T-DNA

transfer

as

monitored

by

virulence

on

wounded Kalanchoe leaves (− avirulent, +++ WT virulence). Effects of mutations on T pilus
production. Extracellular pilin and T pilus, and total cellular pilin were detected as described
in Fig. 5.2 legend. Strains: WT, wild-type A348; ∆B10, non-polar virB10 strain PC1010;
isogenic PC1010 producing Cys substitution mutants as listed. Here, ΔAP denotes deletion
of TraF based alpha 3 and linker region (see (69)). B) β-barrel ribbon structure modeled
with coordinates from pKM101 core outer membrane complex X-ray structure
(DOI:10.2210/pdb3jqo/pdb) (67, 68) using the PyMOL (http://pymol.org/) to construct the
figure. This C-terminal domain (residues 173–377) presents as a non-canonical β-barrel
with a groove marked by the V243C substitution mutation, a flexible base marked by the
S173C and N218C mutations and a conserved RDLDF motif,

the α2,α3 antennae

projection (AP) marked by Q295C and G306C and the flexible bridging domain marked by
D278C. Cys substitution mutations are in blue. Residue numbers labeled in red indicate
pilus defect. Red boxes indicate deletion of region results in pilus defect. Deletion mutations
were constructed by V. Krishnamoorthy. Cysteine substitutions were constructed by I.
Garza. DNA transfer experiments were performed by V. Krishnamoorthy and S.
Jakubowski.
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Figure 5.5 Effects of VirB10 helix projection mutations on T-pilus assembly
Effects of VirB10 helix projection mutations on T pilus assembly. A. Sucrose density
gradient distribution profiles of extracellular VirB2 pilin/T pili produced by WT cells and the
∆AP and ∆BD helix mutants. Here, ΔAP denotes deletion of TraF based alpha 3 and linker
region (see (69)). For comparison, extracellular material from the N218C mutant strain,
which also produces low amounts of surface pilin (Fig. 5.4), was similarly analyzed.
Immunoblots developed with anti-VirB2 antibodies show the distribution profiles of
extracellular pilin in identically prepared 20–70% sucrose density gradients. B. Extracellular
material from WT cells and the ∆AP mutant was fractionated through a Superdex 75
10/300 GL gel filtration column and fractions (listed at top) were analysed for the presence
of VirB2 pilin by immunostaining. Molecular masses of reference proteins are shown below
(in kDa).
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Discussion
VirB10 is predicted to assemble as a structural scaffold as well as a ‘communication’
bridge between the inner and outer membranes. In this study, I collaborated with other
members of the Christie laboratory to characterize the contributions of specific VirB10
domains to DNA transfer and/or T-pilus biogenesis.

The most interesting outcome from

this work was the demonstration that two transmembrane domains, one spanning the inner
membrane and the second spanning the outer membrane, contribute selectively to the
biogenesis of T-pili.
VirB10: a ‘Communication’ Bridge for IM and OM Machine Subassemblies
VirB10 forms close contacts with inner membrane associated T4SS ATPases (45,
107). VirB10 senses ATP binding or hydrolysis activities by the VirB11 and VirD4 ATPases
and, in turn, undergoes a conformational change that is necessary for T-DNA transfer
through the translocation pathway (58, 123). VirD4 spans the inner membrane (159), while
VirB11 associates peripherally at the cytoplasmic face of the membrane (90). Therefore,
the short N-terminal cytoplasmic domain and/or TM domain are predicted to interact with
one or both of these ATPases. Additionally, VirB10 might interact directly with the VirB4
ATPase, which stimulates dislocation of membrane-integrated VirB2 (see Chapter 4 and
(130)). Interestingly, i2 insertions throughout the N-terminal domain and a deletion (Δ2-18)
mutation did not abolish substrate transfer, but did disrupt pilus biogenesis.

A longer

deletion (Δ2-46) of both the cytoplasmic N-terminus and the TM domain abolished both
activities confirming the importance of both domains for VirB10 function. I suggest that the
N-terminal region of VirB10, including the cytoplasmic and TM domains, could mediate
productive interactions with the VirB or VirD4 ATPases that are required for protein
function. In view of the selective disruption of TM domain mutations on pilus biogenesis and
my finding that VirB4 mediates dislocation of the membrane-integrated VirB2 pilin, I favor
the hypothesis that a VirB10 TM domain interaction with the VirB4 ATPase serves to
coordinate delivery of the pilin into the core chamber. Experimental tests of this hypothesis
are proposed in Chapter 7.

VirB10: A Regulator of T-pilus Biogenesis
The isolation of ‘uncoupling’ mutations that selectively disrupt T-pilus production or
substrate transfer suggests that VirB10 might differentially regulate assembly or function of
the secretion channel or polymerization of the T-pilus. In collaboration with other laboratory
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members, I identified three subclasses of ‘uncoupling’ mutations in VirB10: Class I
mutations attenuate substrate transfer levels, but do not disrupt T-pilus production, Class II
mutations abolish T-pilus production, but do not affect substrate transfer, and Class III
mutations selectively disrupt T-pilus polymerization, allowing for release of VirB2 monomers
into the extracellular milieu but without affecting substrate transfer to target cells. The latter
two classes were of primary interest as they arose, respectively, through mutation of the Nterminal region at or near the inner membrane and the AP presumptively spanning the
outer membrane.
The Class II mutations included N-terminal deletion (Δ2-18) and i2 insertions with
the transmembrane region (i2.35, i2.40, i2.45). As discovered and further characterized by
I. Garza, the i2 mutations are located within a sequence (33-LIV*GGVVL*ALSLS*L-46) that
resembles a leucine zipper motif (206). The model I. Garza developed from his studies is
that this Leu zipper motif participates in homo- or heteromeric interactions that are
selectively important for pilus biogenesis.

Again, in view of my studies defining a VirB4

dislocase activity, the most reasonable model is that the VirB10 N-terminal region forms a
productive interaction with the VirB4 ATPase.
The Class III mutations included the ΔAP and ΔBD mutations (fig. 5.4 and 5.5). On
the basis of sequence conservation within this region, most or all VirB10 family members
likely contain an α-helical AP. In view of the Class III phenotype, it is enticing to think that
the AP may play a direct role in facilitating sequential addition of VirB2 subunits during
polymerization. In such a model, the AP might coordinate the packing of pilin monomers to
build the pilus polymer.

According to this model, the AP functions directly in the

morphogenesis of the pilus and might serve as a platform upon which the pili are
assembled. However, an alternative possibility is that the AP functions as a gate that
opens to allow T-pilus extrusion across the outer membrane. According to this model, the
AP functions more passively in the polymerization process, but is still required for extrusion.
The bridging domain is composed of a short β-sheet and flexible sections (Fig. 5.4
B). While the ΔBD mutation did phenocopy the AP deletion, it also showed a significant
reduction in substrate transfer. As discussed in more detail in the next chapter, the bridging
domain contains a number of conserved glycine residues that might regulate translocation
of substrates and extrusion of the T-pilus through the AP pore.
The structures of the pKM101 outer membrane core complex (67, 68) have provided
us with a picture of a T4SS subassembly. It is still unclear if T4SSs use this subcomplex to
build the secretion channel, T-pilus, both structures, or neither structure. The isolation of
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‘uncoupling’ mutations, however, minimally establishes that biogenesis of the secretion
channel and pilus can be genetically separated. Uncoupling mutations have been isolated
in a number of T4SS subunits, including polytopic VirB6 (65), outer membrane core subunit
VirB9 (123), ATPase VirB11(87, 136), ATPase VirD4 (104), VirB2 and the VirB2-like TrbC
pilin of the RP4 plasmid transfer system (130, 160). Future studies aimed at isolating and
characterizing T4SS subassemblies in association with substrates or T-pili should help to
define the requirements for assembly of these two terminal organelles.
Taken together, results of my studies establish that both the TM and AP regions of
VirB10 are critical for T-pilus assembly. Here, I present two models that could account for
the mutant phenotypes (Fig, 5.6).
Model I: The VirB10 TM domain interacts with the pilus assembly factor VirB4 to
enable pilin dislocation directly into the core complex.

According to this model, the i2

mutations disrupt the VirB10-VirB4 interaction and this in turn blocks entrance of the pilin
monomers into the core chamber or alternatively may prevent a necessary structural
transition for incorporation into the T-pilus versus the channel. In earlier studies, the Christie
lab identified VirB subunits that form close contacts with the translocating T-DNA (58).
While VirB4 was required for substrate translocation (45), it did not form close contacts with
the T-DNA substrate. Therefore, VirB4 appears to selectively regulate delivery of the pilin
monomer into the channel without directly regulating passage of secretion substrates. A
disruption in the VirB10-VirB4 interaction mediated by the i2 mutations could thus account
for the Tra+,Pil- ‘uncoupling’ phenotype. This model is also compatible with unpublished
data by S. Jakubowski in our lab that VirB10 interacts with VirB4.
Model II: The AP region serves as a gating domain or polymerization chaperone. In
wild-type cells, the AP regulates passage of the pilus polymer across the outer membrane,
whereas in the ΔAP mutant pilin monomers or short oligomers are extruded. This deletion
may induce a leakiness to the secretion channel that allows for nonspecific release of both
substrate and pilin monomers. As noted above, an alternative possibility is that the AP is
directly involved in T-pilus polymerization, perhaps similar to the mechanism used by the
chaperone-usher pathway of pilus biogenesis, via donor-strand exchange (207).
In conclusion, our findings support the notion that VirB10 functions as a
‘communication’ bridge between the inner and outer membranes and possibly also serves
as an outer membrane gated pore. Moreover, on the basis of the “uncoupling” phenotypes
identified in the TM and AP regions, I propose that VirB10 differentially regulates assembly
of the T-pilus or the secretion channel.
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Figure 5.6 Models of VirB10 TM and AP domain involvement during T4SS T-pilus
assembly
Left figure depicts the proposed function of the VirB10 TM domains in establishing
productive contacts with VirB4. Two residue transmembrane insertions (i2-TM; depicted by
yellow stars) were shown to specifically block T-pilus biogenesis without affecting substrate
transfer. VirB2 may be blocked (red ‘X’) from entering the core channel complex or fail to
make a structural transition (small red ‘x’) necessary for incorporation into the T-pilus due to
loss of specific contacts between VirB10 and VirB4. Right figure highlights a model in
which the VirB10 AP serves as an outer membrane gate and/or polymerization chaperone
for VirB2. Removal of the AP (ΔAP) allows both substrate and VirB2 monomers to be
released into the extracellular milieu. In the absence of the AP, VirB10 cannot mediate
polymerization through an indirect (e.g. channel gating, promoting contact with another VirB
subunit) or possibly direct mechanism (e.g. donor-strand exchange to promote pilus
assembly, see (207)). Outer membrane complex was modeled with co-ordinates from
pKM101 core outer membrane complex X-ray structure (DOI:10.2210/pdb3jqo/pdb) (67, 68)
using the PyMOL (http://pymol.org/) and modified to construct this figure. OM: outer
membrane; P: periplasm; IM: inner membrane.
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Chapter 6: Characterization of a virB10 Mutant Conferring Release of VirE2 to the
Extracellular Milieu While Selectively Blocking T-Pilus Biogenesis

NOTE: This work was performed as part of a collaboration between the laboratories of Dr.
Peter Christie and Dr. Lois Banta (Williams College - Biology Department - Williamstown,
Massachusetts). This work describes a mutation that was first isolated in an experimental
screen designed and performed by Dr. Lois Banta. Further characterization of this mutation
was performed by Dr. Eric Cascales and Jennifer E. Kerr under the supervision of Dr. Peter
Christie.

Each person contributed to the development and design of the experiments.

Members of the collaboration responsible for data discussed are indicated.
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Introduction
Type IV secretion systems (T4SS) mediate the movement of DNA and/or protein
substrates into a variety of recipient cells or into the milieu (2, 3, 15, 30). The
Agrobacterium VirB/VirD4 T4SS is dedicated to the movement of both T-DNA and protein
substrates into plant and other cell types based on a cell-contact dependent mechanism
(33, 34, 60, 64, 208). These T4SSs span the entire bacterial cell envelope and comprise a
conduit for substrates to pass en route to target cells (2, 3, 15, 30). Three VirB/VirD4 T4SS
components, the cell-envelope-spanning subunit VirB10 together with the outer-membraneassociated subunits VirB7 lipoprotein and VirB9, form a stable T4SS subassembly that is
known as a ‘core’ complex (2, 30). These ‘core’ subunits are phylogenetically conserved
among T4SSs of Gram-negative bacteria (15), and therefore structure-function studies of
paradigmatic ‘core’ complexes likely will identify mechanistic features of broad biological
importance.
Recently, structural information was obtained for a ‘core’ complex of the Escherichia
coli pKM101 conjugation system by cryoelectron microscopy (cryoEM) and X-ray
crystallography (67, 68). In this ‘core’ complex, homologs of VirB7, VirB9 and VirB10
assemble together as a 185 Å ring composed of 14 copies of each subunit. On the basis of
the cryoEM images, VirB10-like TraF was postulated to span the inner membrane and
project through the periplasm to the outer membrane. In view of the more recent X-ray
structure, it was further suggested that an α-helical domain of TraF termed the antennae
projection (AP), spans the outer membrane, such that the 14 AP’s in the core complex form
an α-helical outer membrane pore with an opening of ~20 Å in diameter. At the inner
membrane, an N-terminal transmembrane (TM) domain anchors TraF in the membrane,
and the 14 copies of TM domains in the core complex form a ring of a 55 Å in diameter.
As suggested for the pKM101 core structure, a presumptive VirB7/VirB9/VirB10
core complex likely functions as a structural scaffold during machine biogenesis. In support
of such a function, the three VirB proteins mutually stabilize each other as well as other
VirB subunits. Moreover, S. Jakubowski in our laboratory recently succeeded in enriching a
ring-shaped complex resembling that of the pKM101 core and composed minimally of these
3 subunits (unplublished data). Another interesting feature identified for the VirB10 subunit
is that it senses ATP binding or hydrolysis activities of the VirD4 and VirB11 ATPases. In
response, VirB10 undergoes a structural transition, identified as a change in susceptibility
to an endoprotease. This structural change is important for stable complex formation
between VirB10 and the VirB7/VirB9 complex (83).
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E. Cascales, a postdoctoral fellow in the Christie laboratory, developed a substrate
trapping assay based on the chromatin immunoprecipitation assay (ChIP). In this assay,
cells are treated with formaldehyde to crosslink the translocating T-DNA to subunits of the
T4SS channel. Following solubilization, subunits are immunoprecipitated with the anti-VirB
antibodies, and co-precipitated crosslinked T-DNA is assessed by PCR amplification. With
this assay, E. Cascales supplied evidence that the energy-activated form of VirB10
regulates substrate transfer through the distal portion of the channel composed of the VirB2
pilin and VirB9 subunits (58, 83). Accordingly, VirB10 is postulated to function as a ‘gatekeeper’ that regulates substrate translocation across the outer membrane by a mechanism
dependent on sensing of inner membrane ATPase activities. One pototential protein that
undergoes gated release is VirE2, a single-stranded DNA-binding protein that interacts with
the T-DNA, forming the T-complex. VirE2 protects the T-DNA from cytoplasmic nucleases
in the plant cell and mediates delivery of the T-DNA to the plant nuclear pore with the help
of VirE3 (47-52).
The proposed role of VirB10 as an energy-activated regulator of substrate transfer
across the outer membrane remains to be experimentally tested. In this investigation, I
participated in a study with our collaborator Dr. Lois Banta (Department of Biology, Williams
College, Williamstown, MA, USA) aimed at testing the model that VirB10 regulates
substrate translocation across the outer membrane.

In a genetic screen, Dr. Banta’s lab

isolated a substitution mutation in VirB10 that confers leakage of a secretion substrate
across the outer membrane. Here, I present results of my studies confirming both the
‘substrate leaky’ phenotype and an observed disruption of T-pilus biogenesis. I also report
results of experiments indicating that the mutation, which is located near the AP region,
does not confer nonspecific disruption of outer membrane integrity. Our collective findings
add to a body of evidence that VirB10 functions as an energy-activated, outer membrane
‘gate-keeper’,
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Results
The VirB/D4 T4SS translocates substrates across the entire cell envelope by a
mechanism requiring direct contact with target cells (33, 34, 209). The Lois Banta lab
designed and performed a screen to identify ‘leaky’ T4SS channels. Her lab screened
~12,000 strains expressing virB10 mutant alleles for the release of functional, FLAGtagged VirE2 (FLAG-VirE2) derivative to the cell surface. One mutant strain was isolated
that showed a significant increase in release of FLAG-VirE2 in comparison with a wild type
T4SS.

The virB10 allele was sequenced and found to harbor a single mutation that

resulted in a substitution of an arginine for glycine at residue 272. Here, I present
additional characterization data for this VirB10 G272R mutant. Modeling of the G272R
mutation within the pKM101 core complex was performed by Dr. Gabriel Waksman.

virB10 Mutant Confers Release of VirE2 to the Extracellular Milieu
In agreement with the Banta lab finding, I found that the G272R mutation confers
increased levels of surface exposed FLAG-VirE2 substrate in comparison to both the
isogenic ΔvirB10 mutant or the ΔvirB10 mutant producing native VirB10 (Fig. 6.1A). FLAGVirE2 accumulated at comparable total cellular levels in each strain background. The
G272R mutation also did not affect cell viability in virB induction medium (ABIM) (Fig. 6.1B).
The G272R mutation may directly affect secretion channel gating or it could nonspecifically disrupt outer membrane integrity. In order to test this, I measured growth of a
ΔvirB mutant producing native VirB10 or the G272R mutant in the presence of the large
antibiotic vancomycin or anionic detergent SDS.

I also assayed for the release of

periplasmic-localized proteins RNase and ChvE. The outer membrane of Gram-negative
bacteria normally provides a barrier to potentially harmful molecules. Porins at the outer
membrane allow only the transit of small molecules (<600 Da) (210-212). Vancomycin is a
large antibiotic (~1,500 Da) that targets the N-acetylmuramic acid and N-acetylglucosamine
peptide subunits from incorporating into the peptidoglycan matrix and therefore
predominantly affects Gram-positive bacteria cell wall synthesis (213, 214); however, an
ungated channel or pore at the outer membrane could allow for transit of the drug into the
periplasm of Gram-negative bacteria (215). Likewise, the outer membrane also protects
from the effects of anionic detergents (216).
The G272R mutant showed increased sensitivity to both vancomycin and sodium
dodecyl sulfate (SDS) (Fig. 6.2A and B). The G272R mutant strain grew slower in the

107

Figure 6.1 Effects of the G272R mutation on VirE2 release and growth
A) N-terminally FLAG-tagged VirE2 (Flag-VirE2) was produced in a nonpolar ΔvirB10
mutant strain (PC1010) and and the ΔvirB10 mutant synthesizing native VirB10 or the
G272R mutant protein.

Upper, total cellular levels of FLAG-VirE2 assessed by

immunostaining with anti-Flag antibodies. MW, molecular weight markers with sizes in
kilodaltons (kDa) listed at left. Lower, FLAG-VirE2 surface display on the corresponding virinduced strains as monitored by colony immunoblotting with anti-FLAG antibodies. B)
Growth curves of PC1010 producing native VirB10 or the G272R mutant upon
resuspension of cells in vir-induction media, as described in Materials and Methods.

Note: FLAG release phenotype first observed in the Lois Banta lab. Shown here is a repeat
of that assay in A lower panel.
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Figure 6.2 Effects of G272R on membrane integrity, as monitored by vancomycin and
SDS sensitivity and release of preiplasmic proteins
A & B) PC1010 (ΔB10) producing native VirB10 or the G272R mutant were suspended in
vir-induction media containing vancomycin (50 or 100 μg/ml) or SDS (0.5 %) and
growth/lysis was monitored for 18 h. C) PC1010 (ΔB10) cells lacking or producing native
VirB10 (B10) or G272R were assayed for RNase release from intact cells on RNAcontaining plates as described in Materials and Methods. Presence of cellular RNase was
confirmed by addition of sonicated cell extracts to RNA-containing plates. Strains were
assayed similarly for release of periplasmic ChvE as monitored by development of colony
blots with anti-ChvE antibodies. Production of cellular ChvE was assessed by spotted in
sonicating cell extracts on nitrocellulose and development with anti-ChvE antibodies.
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presence of 50 μg/ml vancomycin compared to an isogenic strain producing native VirB10
and the difference was more evident with the addition of 100 μg/ml vancomycin (Fig. 6.2A).
Growth was prevented and cells were presumably lysed in both the G272R mutant and the
functionally wild-type strain by addition of 0.5% SDS; however, the G272R mutant showed
a more pronounced sensitivity (Fig. 6.2B). In addition to inhibiting molecules from entering
the cell, the outer membrane prevents periplasmic proteins and large molecules from
exiting the bacterium. A. tumefaciens possesses RNase and the sugar-binding protein
ChvE in the periplasm (217). If the G272R mutant disrupted outer membrane integrity,
these proteins might be released to the cell surface. However, the G272R mutant did not
show increased release of the periplasmic proteins as monitored by surface colony blots for
ChvE and an RNA degradation assay for RNase in comparison to a ΔvirB10 mutant or an
isogenic strain producing native VirB10 (Fig. 6.2C) (139). Thus, G272R likely disrupts the
gating of the secretion channel at the outer membrane pore, allowing for release of FLAGVirE2 substrate and increased uptake of molecules that are typically unable to cross the
outer membrane.

G272R is Locked in an Energy-Activated Conformation
In wild type cells, VirB10 undergoes a conformational change in response to
sensing ATP binding or hydrolysis by VirD4 and VirB11. This energy-activated structural
transition results in exposure of a protease cleavage site that can be monitored by the
presence of a ~40-kDa degradation product following protease treatment of spheroplasts
(83). In the absence of ATPases VirD4 and VirB11 or in cells depleted of cellular ATP
levels with arsenate treatment, VirB10 maintains a protease-resistant conformation (48
kDa) (83).

Interestingly, Dr. E. Cascales showed that the G272R mutant protein is

degraded to the ~40kDa species even in the presence of arsenate (E. Cascales, personal
communication). The data suggest that the G272R mutant protein might ‘lock’ VirB10 into
the energy-activated conformation.

G272R is Permissive for Intercellular Substrate Transfer, but Blocks T-Pilus
Biogenesis
Next, the G272R mutation was tested for its potential impact on substrate transfer to
recipient cells or T-pilus biogenesis. Substrate transfer to target cells was monitored by a
plant tumor assay and conjugative transfer of a mobilizable IncQ plasmid. Interestingly,
despite the apparent ‘leaky’ phenotype, the G272R mutation did not disrupt substrate
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transfer of oncogenic T-DNA and protein substrates to plant cells as shown by appearance
of plant tumors, or the conjugative transfer of an Inc Q

plasmid

substrate

to

bacterial

recipient cells (Fig, 6.3A). In contrast, neither the VirB2 pilin nor the pilus-associated protein
VirB5 were detectable on the cell surfaces or in the high-molecular-weight shear fraction of
the G272R mutant strain (Fig. 6.3B). These findings indicate that the G272R mutation
completely blocked extracellular T-pilus production. Cellular levels of VirB2 and VirB5 were
unaffected by production of the G272R mutant protein. Therefore, the G272 mutation is
another example of an ‘uncoupling’ mutation that renders cells Tra+ and Pil-.

An AP Deletion Mutation Confers a Partial Gating Defect
VirB10 is postulated to form the outer membrane pore in the pKM101 core complex
structure by creating a halo of interlocking alpha-helical projections extending from the top
of the β-barrels. In Chapter 5 and our publication reporting the results of the VirB10
mutational analysis (69), I reported that deletion of these antennae projections (AP) and the
associated bridging domains also resulted in Tra+, Pil- phenotype. Unlike the G272R
mutation that completely abolished release of extracellular VirB2, these deletion mutants
mediated the release of pilin monomers into the milieu. I hypothesized that since these
deletion mutants release nonpolymerized VirB2, they may also release VirE2 to the surface,
even in the absence of a target cell. Interestingly, strains producing the ΔAP or ΔBD mutant
proteins did not release FLAG-VirE2 to the milieu (representative data are shown for the
ΔAP mutant strain in Fig. 6.4A). Both deletion mutants were also evaluated for nonspecific
effects on the outer membrane. As shown for the ΔAP mutant (Fig 6.4), the mutant strains
did not show enhanced vancomycin sensitivity or release of periplasmic proteins RNase or
ChvE. The strains showed only a mild defect in the presence of 0.5% SDS relative to the
isogenic strain complemented with native virB10 ( Fig. 6.4D-E). These results suggest that
deletion of this region does not phenocopy the putative ‘open’ channel defect associated
with the G272R mutation. Deletions in or around the AP region of VirB10 appear to
selectively release VirB2 monomers without influencing secretion channel substrate gating
or outer membrane integrity.
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Figure 6.3 Effects of G272R mutation on DNA transfer, surface display of VirB2 pilin
and the pi
lus-associated protein virB5
A) Levels of substrate transfer to plants, as monitored by virulence assays, and IncQ
plasmid transfer to agrobacterial recipients. B) PC1010 (ΔvirB10) lacking or producing
native VirB10 or the G272R mutant were assayed for surface-accessible VirB2 and VirB5
by colony immunoblotting, and for the presence of both proteins in material recovered in the
shear fraction.

Corresponding analyses with PC1002 (nonpolar ΔvirB2 mutant) shows

specificity of the anti-VirB2 antibodies, and also the G272R mutation also blocked delivery
of VirB5 to the cell surface independently of VirB2 production. Bottom panels show steadystate cellular levels of VirB2 and VirB5 in the various strains.
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Figure 6.4 Effects of the ΔAP (Δ302-337) mutation on VirE2 release, DNA transfer, cell
growth, and outer membrane integrity
A) Effect of the ΔAP mutation on release of FLAG-VirE2. Samples were prepared and
analyzed as described in Fig. 6.1A. The ΔAP mutant strain displayed only slightly reduced
levels of substrate transfer to plants, as monitored by virulence assays, and IncQ plasmid
transfer to agrobacterial recipients. B – E) as described in Fig. 6.2 legend, showing that the
ΔAP mutation did not result in diminished cell growth, enhanced sensitivity to vancomycin
or SDS, or release of periplasmic RNase or ChvE. My earlier studies showed that the ΔAP
mutation disrupts polymerization of VirB2 into the T-pilus (See Chapter 5).
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Discussion
Export of virulence factors is typically tightly regulated in response to environmental
as well as host-derived signals, and in many cases requires physical contact with a
recipient cell (33, 34, 60, 64, 208, 218). The outer membrane location of a portion of
VirB10 in the pKM101 core channel complex led to a hypothesis that VirB10 may directly
serve as a gate for the T4SS substrate channel. To test this model, VirB10 mutant strains
were screened for leakage of protein substrate to the surface in the absence of target cell
contact. The VirB10 G272R mutation conferring such a phenotype was mapped to a
highly-conserved glycine residue in the bridging domain (BD), which links the antennae
projection (AP) to the β-barrel of VirB10 homolog TraFpKM101. Previously, I showed that
deletion of this BD resulted in attenuated levels of DNA transfer (see chapter 5). Here, I
show that, unlike the G272R substitution mutation, deletion of this region as well as the
associated AP that extends from the β-barrel forming the outer membrane cap of the core
complex does not result in leakage of protein substrates to the milieu. This work
emphasizes not only the importance of the bridging domain but also the general role of
VirB10 in mediating translocation of substrates across the outer membrane.
The features of VirB10 as a putative envelope spanning subunit (67, 68) and as a
coupler of inner membrane energy to outer membrane translocation (83) suggests VirB10
might regulate channel activity at the outer membrane. Here, I showed that the G272R
mutation appears to specifically disrupt the T4SS channel gating versus non-specifically
disrupting the outer membrane (Fig, 6.1). The data from E. Cascales that this mutation
confers a constitutive ‘energy-activated’ conformation even in ATP-depleted cells is in line
with the idea that the G272R mutation locks the channel into an ‘open’ configuration.
It is important to note, however, that in wild-type cells the energy-activated form of
native VirB10 is also proteolytically degraded. Yet, wild-type cells do not release detectable
levels of protein substrates (Fig. 6.1 A and data not shown). G. Waksman located the
G272R mutation in the VirB7/VirB9/VirB10 core complex modeled from the pKM101 X-ray
structure, showing its exposure on the interior surface of the core complex near the outer
membrane (Fig. 6.5 A and B). This mutation, which consists of the introduction of a positive
charge, may cause a conformational change that disrupts gating of the outer membrane
pore leading to substrate leakage. Thus, while the G272R mutation appears to lock the
channel into an open conformation, in wild-type cells additional checkpoints must be

118

Figure 6.5 Modeling of G272R in pKM101 crystal structures
A)

Space-filling model of the pKM101 core complex comprised of homologs of VirB7

(TraN) in pink, VirB9 (TraO) in blue, and TraF (VirB10) in gray corresponding to the βbarrel/linker domains and yellow/green to the AP α-helices and intervening loop. VirB10
Gly272, corresponding to TraF Gly294, is indicated in red. B) Ribbon model of VirB10
(TraF) showing β-barrel, an α-helical lever arm extension, and antennae projection (AP).
The G272R mutation sits in an unstructured linker domain between the β-barrel and AP.
Modeled by Dr. Gabriel Waksman.
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present to prevent the ‘energy-activated’ channel from translocating substrate until
productive contact with target cells is established. In view of these observations, it is
interesting to suggest that transenvelope VirB10 may also function as a transducer of a cellcontact-mediated signal(s) to activate substrate transfer through the T4SS.

Such a

transducer function could be required for propagation of the ‘mating’ signal, an unspecified
recipient-produced signal that was postulated to exist by early investigators of the Fplasmid transfer system (219-221). The G272R mutation might bypass this signal rendering
cells transfer competent even in the absence of a target cell.
The proposed outer membrane gating mechanism likely requires energy; however,
energy is not readily available at the outer membrane. The periplasm does not maintain a
pool of ATP and the outer membrane is unable to sustain an electrochemical gradient.
VirB10 sensing of ATP binding or hydrolysis by the inner membrane channel ATPases,
likely results in structural changes necessary not only for productive complex formation but
also dynamic opening and closing the outer membrane pore. A similar mechanism for
energy transduction to the outer membrane is seen in the TonB system that uses the inner
membrane proton motive force, as well as the aerolysin secretion system of Aeromonas
hyrophila, which relies on ATPase ExeA and TonB-like protein ExeB (222, 223). VirB10
might differ from TonB in that a target cell contact might also serve to regulate channel
gating. Another notable difference is that whereas TonB activates transport by inducing
conformational changes in an outer membrane transporter, VirB10 likely regulates
assembly or activity of its own outer membrane AP pore.
Finally, it is of considerable interest that the G272R mutant, similar to the ΔAP and
ΔBD (see chapter 5), was also defective in T-pilus biogenesis (Fig. 6.3). The G272R
mutation completely blocked extracellular release of VirB2 and pilus-associated protein
VirB5, whereas the deletion mutants showed disrupted pilus production but still allowed for
release of monomers or short oligomers of VirB2. The G272R mutation appears to block
delivery of VirB2 and VirB5 across the outer membrane, either as monomers or polymers,
while the deletion mutants specifically disrupt T-pilus polymerization. It is still unknown if
the T-pilus initiates polymerization from the inner membrane, extending through the core
complex, or at the outer membrane using, perhaps, VirB10 as a platform. Cysteine
accessibility labeling of the VirB2 cellular-associated and T-pilus forms supports the latter
model (see Chapter 1 and (130)). Together the predicted flexible nature of the VirB10
AP/BD region, its position at the outer membrane pore, and the genetic evidence from
mutations provide support for a model in which VirB10 actively participate during T-pilus
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polymerization. Although details of the T-pilus polymerization reaction(s) remain unknown,
a possible mechanism of action of the AP is offered through studies of the chaperone-usher
pathway of Pap pilus biogenesis. For these pili, which are phylogenetically unrelated to
T4SS-encoded pili, subunit polymerization takes place by a ‘donor-strand exchange’
mechanism, wherein a chaperone provides a temporary β-strand for folding of the pilin
subunit; the next incoming pilin subunit displaces the chaperone β-strand with one of its
own, resulting in polymerization at the outer-membrane (207). Conceivably, the VirB10 AP
functions as a donor strand to promote folding of VirB2 pilin monomers; during the
polymerization process, a hydrophobic helix of one pilin subunit might replace the VirB10
AP. Further studies will test this model vs. an alternative in which the AP serves more
passively as a gating domain to regulate pilus/pilin passage across the outer membrane.
In conclusion, the G272R mutation as well as the bridging domain and antennae
projection deletions highlights the role of VirB10 in substrate trafficking across the outer
membrane and assembly of T-pilus. It is curious to think how a single machine
subassembly can remain ‘open’ for protein substrates but ‘closed’ for VirB2 release. VirB10
might differentially regulate assembly/function of the secretion channel and T-pilus by
distinct mechanisms and possibly as a component of different VirB subassemblies.
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Chapter 7: Summary, Future Studies, and Perspectives

NOTE: Electron microscope images presented in this chapter were taken by Dr. Angel
Paredes (University of Texas Health Science Center – Medical School – Pathology
Department – Houston, TX) and denoted in the figure legend. I performed all sample
preparations for electron microscope experiments.
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Summary
The focus of this work has been to further characterize A. tumefaciens VirB2 pilin
with respect to assembly of the secretion channel and T-pilus. My work focused primarily on
VirB2, VirB4, and VirB10 which are all essential components of the VirB/D4 type IV
secretion system (T4SS) (25, 104, 128, 133). A primary goal of the research presented
here was to gain a broader understanding of the energetic, structural, and molecular events
underlying the contributions of VirB2 pilin in assembly of the T4SS. Currently, there is little
structural information for the VirB2 pilin subunit except for basic in silico analysis (115, 116,
224).

There is some biochemical data describing early processing of pro-pilin to mature

pilin (25) and contributions of certain VirB subunits to T-pilus biogenesis (122). However,
prior to my studies, the specific roles of the VirB ATPases or of VirB10 in promoting
incorporation of the pilin into the secretion channel or T-pilus was fundamentally unknown.
Studies summarized below bring to light new findings regarding intermediate steps in the Tpilus pathway and assign specific roles for ATPases VirB4 and VirB11 along with domain
contributions of VirB10.
Studies presented in chapter 3 examine the detailed structure of VirB2 at the inner
membrane, as part of the secretion channel, and within the T-pilus by use of scanning
cysteine accessibility method. Past studies using sequence hydropathy had established
that VirB2 possessed two hydrophobic stretches that likely created two transmembrane
domains at the inner membrane. VirB2 was predicted to move from the inner membrane
allowing for T-pilus polymerization in the presence of the remaining T4SS VirB subunits. I
predicted that VirB2 would likely undergo a structural transition in response to T4SS
activation. I tested this hypothesis by inserting unique cysteine residues along the length of
VirB2 and assessing for changes in Cys labeling in the presence and absence of the VirB
proteins. Initial phenotypic studies showed i) Cys substitutions at the N and C termini
disrupted protein stability or function and ii) a C-terminal mutation (G119C) selectively
abolished secretion channel activity without affecting T-pilus production. I then defined the
inner membrane topology of VirB2 - comprised of two transmembrane regions, a small
cytoplasmic loop, and a long periplasmic loop containing the covalently linked N and C
termini. Next, I showed the cellular-associated form of VirB2 demonstrated differences in
labeling consistent with extraction of the pilin from the inner membrane when in the
presence of the other VirB subunits. I also showed that the labeling patterns of Cys mutants
produced in a Tra+, Pil- uncoupling mutant strain matched the isogenic, phenotypically wildtype strain, but differed appreciably from labeling patterns of pilins assembled into T-pili. In
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the isolated T-pilus, Cys residues at positions 64, 67, and 77 but not elsewhere in the pilin
were labeled, indicating that only a short motif comprised of hydrophilic and hydrophobic
residues is surface-exposed. These findings supplied the first information about the pilin
structural organization when assembled as an inner membrane pilin pool, and when
incorporated into the secretion channel and the T-pilus.
Chapter 4 focused on determining the role of energy during early steps in the T-pilus
biogenesis pathway. I proposed that the extraction of VirB2 from the inner membrane for
further machine assembly requires one or more of the VirB ATPases. I again used my
collection of Cys-substituted pilins to monitor differences in the VirB2 structural state in
different genetic contexts. I determined that Cys-substituted pilins produced in strains
lacking or producing the VirB4 or VirB11 ATPases exhibited differences in MPB-labeling
patterns. I further showed that VirB4 synthesis, but not the Walker A box binding motif
mutant, was correlated with labeling of a VirB2 cytoplasmic residue Cys94 regardless of the
presence of other VirB proteins. Additionally, co-synthesis of VirB4 and VirB11 was
correlated with labeling of periplasmic Cys64. I also showed that VirB2 and VirB4 formed an
immunoprecipitable complex. Finally, I determined that VirB2 was released from the inner
membrane in cells producing VirB4, but not in a ΔvirB4 mutant strain or a ΔvirB4 strain
producing a VirB4 Walker A motif mutant proteins but no other VirB proteins. Overall, my
findings support a model in which the VirB4 ATPase catalyzes extraction of VirB2 pilin from
the inner membrane. Although the VirB11 ATPase is not required for pilin dislocation, it
does seem to participate in modulating the VirB2 structural state during or after dislocation.
In chapter 5, I presented work characterizing the contribution of individual VirB10
domains to T-pilus biogenesis and substrate transfer. VirB10 was previously shown by the
Christie lab to sense ATP energy at the inner membrane resulting in a conformational
change within VirB10 leading to complex formation (83). A series of mutations were
generated, by V. Krishnamoorthy and I. Garza, to determine the function of specific regions
within VirB10. Phenotypic studies identified Tra+, Pil- “uncoupling”: mutations that mapped
to the N-terminal cytoplasmic region and transmembrane domain and the C-terminal α2,α3
helix (AP) extending from the β-barrel domain.

On the basis of the “uncoupling”

phenotypes, I propose that the extreme N-terminus, TM α-helical registry, and β-barrel
antennae projection, assisted by the bridging domain, form specific intermolecular
interactions that are critical for biogenesis of the T-pilus but not for a functional secretion
channel. Together the data imply that VirB proteins can alternatively assemble as a
secretion channel or a platform for the T-pilus.
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In chapter 6, I focused on further characterizing a mutant from the laboratory of Dr.
Lois Banta, identified during a screen for ‘leaky’ substrate channels. VirB7, VirB9, and
VirB10 subunits form a stabilizing core complex early during activation of the T4SS (2, 3,
30). A detailed crystal structure of the pKM101 outer membrane core complex, from the
Waksman lab, has revealed that VirB10 forms the external most part of the outer
membrane pore. These findings have led to our hypothesis that VirB10 regulates substrate
passage through the distal portion of the translocation channel. The Banta lab screened for
mutations that would confer release of a tagged protein substrate (FLAG-VirE2) to the
surface in the absence of a target cell. The screen identified one mutation G272R that
mediated VirE2 release and also rendered the mutant insensitive to cellular ATP depletion.
Notably, G272R was blocked for T-pilus biogenesis but unaffected in substrate delivery to
plant and bacterial recipient cells. Modeling of the mutation by Dr. Gabriel Waksman
showed that the G272R mutant is located near the antennae projection (AP) within the
bridging domain (BD) of VirB10 homologue TraFpKM101. The AP and BD form the outer
membrane pore and deletion of these regions phenotypically resembled the G272R
mutation by allowing substrate transfer but blocking T-pilus assembly; however, these
deletions did not permit leaking of FLAG-VirE2. I propose that i) the G272R mutation
disrupts regulation of substrate trafficking by locking the secretion channel in an ‘open’
position resulting in substrate leakage, and ii) the G272R mutation as well as the partial AP
and BD deletion mutations selectively disrupt pilus polymerization by preventing formation
of an outer membrane assembly platform. How the G272R mutation can confer substrate
leakage without affecting intercellular substrate transfer, while also blocking pilus
biogenesis, are intriguing questions for further studies. A working model is that the VirB10
contributes to substrate transfer or pilus biogenesis by modulating the structural
organization of its AP and BD as a function of energy transduction from the inner
membrane ATPases and sensory recognition of an extracellular signal(s) derived from a
productive target cell interaction.
This works highlights the intriguing yet complex nature of type IV secretion systems.
My studies contributed novel information pertaining to i) the structural organization of the
VirB2 pilin in the inner membrane, secretion channel, and T-pilus ii) the role of an ATPase
in driving pilin dislocation, and iii) contributions of VirB10 domains to T-pilus biogenesis and
substrate transfer across the outer membrane. While these findings significantly advance
our understanding of the structural, energetic and molecular events underlying type IV
secretion system assembly and function, clearly there are still many unanswered questions.
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Future Studies
The following experiments are meant to extend the analyses of the studies presented here.
Test the model that VirB2 accumulates in the inner membrane as a prerequisite to its
polymerization into the T-pilus and secretion channel
Although early processing of the VirB2 propilin involving cleavage of the signal
sequence and cyclization proceed via integration into the inner membrane, there is little
experimental support for the notion that the mature pilin accumulates a pool in the
membrane (delayed incorporation) (175, 225).

An alternative model is that upon

processing the pilin is immediately dislocated for polymerization into the secretion channel
or pilus. In chapter 3, I presented evidence that the VirB2 Cys51 mutant protein is labeled in
the absence but not the presence of other VirB proteins. This labeling pattern is not
consistent with the accumulation of a pilin pool, as it is unlikely that the synthesis of other
VirB proteins would result in extraction of all pilin monomers. Thus, at least a subset of the
Cys51-substituted pilins should still label even in wild-type cells. The one caveat to this line
of reasoning, however, is that the Cys51 substitution is a loss-of-function mutation. This
phenotype prevents firm conclusions about findings relating to the structural organization of
this mutant.
Further studies evaluating the pilin ‘pool’ model would involve screening other Cyssubstitutions that do not block protein function, but display the same MPB labeling pattern
as the Cys51 mutant protein.

Such a mutation would constitute compelling genetic

evidence against the pilin pool model. Another line of study would involve use of different
promoters to modulate the timing of VirB2 synthesis relative to the other VirB proteins. For
example, virB2 expression by a tightly-controlled promoter could be used to synthesize a
pool of membrane-integrated pilin prior to synthesis of the remaining VirB proteins from the
acetosyringone-inducible virB promoter.

Two such promoters that function in A.

tumefaciens include the salicylic acid inducible nah promoter (Pseudomonas) and
arabinose-inducible BAD promoter (Escherichia coli) (226, 227). In addition, a new set of
LacI-based expression vectors was created for E. coli that are inducible by addition of
isopropyl β-D-1-thiogalactopyranoside (IPTG) (228). Temporal expression of virB2 would
be monitored by transcript and protein accumulation via RT-PCR and Western blot
analyses, respectively. Cells would be induced for synthesis of VirB2, then the inducing
signal would be removed by centrifugation of cells and resuspension in fresh media. The
remaining virB genes would be induced from the native promoter and assayed over time for
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accumulation of pilin at the cell surface, pilus production, protein stability, and substrate
transfer. Variations on this temporal gene expression assay could include reversing the
time course of virB2 vs. other virB gene expression, and differential synthesis of VirB4 with
other VirB proteins to monitor the kinetics of pilin dislocation from the membrane.

These

kinds of studies should allow for a rigorous test of the pilin ‘pool’ model.
It is also of central interest to define the kinetics of pilus assembly and where on the
cell surface the pilus polymerizes. Other studies have used immunogold labeling and phage
fluorescence (175, 225, 229, 230) to observe the movement of pilin subunits from a preformed pool and monitor pilus extension. A similar technique could be used in A.
tumefaciens; however, this application is more difficult in Agrobacterium because of its
smaller size and lack of T-pilus-binding phage. A potential fluorescence recognition site
that could be used is Fluorescein Arsenical Hairpin binder (FlAsH) which is a tetra cysteine
motif that strongly interacts with fluorophores. This application might allow for real-time
monitoring of pilus biogenesis and perhaps movement of pilin monomers across the cell
envelope (231). However, tagged versions of VirB2 have proven difficult to produce. I
engineered seven FLAG and tetra-cysteine motifs in different locations along the length of
VirB2 using mutagenic PCR or cloning. I designed an SphI flanked FlAsH tag Kanamycin
resistance cassette to place the FlAsH tag into the SphI site created by some of the Cys
substitution mutants within VirB2 (Fig. 7.1A).

Two tags could be accommodated without

loss of protein function: a FLAG tag placed directly after residue 85 and a tetra-cysteine
motif (FlAsH) placed in the SphI site created by the Cys83 substitution resulting in Ala-CysCys-Pro-Gly-Cys-Cys-Cys (Fig. 7.1B). It is interesting that residues 83 and 85 are in the
domain II hydrophobic patch within VirB2, near the cytoplasmic loop. Even though the
FLAG tag introduces a cluster of negative charges near this loop, the tagged protein is still
functional. Since this would violate the ‘positive-inside’ rule of von Heijne (164), it is
intrinsically interesting to explore the mechanism by which this FLAG-tagged variant inserts
into the inner membrane. However, for the pilus assembly kinetics and positioning studies,
unfortunately, neither the FLAG- or FLAsH-tagged variants could be detected with antiFLAG or addition of the FLAsH reagent (J. Kerr, data not shown). Because both tags might
be buried in the pilus lumen, I suggest that additional FLAG tags be inserted within the
region of VirB2 that I showed to be surface-displayed in the isolated T-pilus, e.g., between
residues 67-77.

This collection of FLAG or FlAsH tagged variants could be used in

fluorescence microscopy studies aimed at characterizing the timing and placement of pilus
polymerization on the cell surface.
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Figure 7.1 Schematic of FlAsH tag cassette and effects of tag introduction into VirB2
on surface display of VirB2 and virulence
A) Schematic of FlAsH tag cassette. Kanamycin resistance cassette (KanR) was PCR
amplified from broad host range plasmid pXZ151 and flanked with a SmaI enzyme site and
half of the FlAsH tag with an SphI site. Triangles represent enzyme sites. B) Extracellular
blot (surface) assay of Flag and FlAsH tagged versions of VirB2. Negative controls ΔvirB
operon and ΔvirB2, and positive control WT: wild type strain A348. Mutagenic PCR was
used for introduction of Flag 62, 85 and FlaSH 63, 114. FlAsH tag cassette in (A) was used
for introduction of the tetra-cysteine motif at SphI sites created by Cys substitutions at
residues 67, 83, and 111. Kanamycin cassette was removed following cloning by a SmaI
digest. Virulence monitored by plants inoculation and scored on a scale of no virulence - to
wild-type virulence +++.
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Defining the Structure of the T-Pilus and Pilin Subunit Packing
Studies presented in chapter 3 showed that VirB2 adopts different structural states in
the inner membrane, secretion channel, and T-pilus. MPB-labeling further revealed that a
patch of both hydrophilic and hydrophobic residues is exposed on the T-pilus surface. This
presented the first structural information about the VirB2 pilin packing geometry within the
T-pilus. Future studies aimed at defining the T-pilus structure are important because of
another central, but unresolved question in the field of T4SSs: do substrates travel through
the pilus? Although the isolation of Tra+, Pil- ”uncoupling” mutations establishes that the Tpili are not necessary for substrate transfer, other investigators suggest that T4SS-encoded
pili function as conduits for substrate transfer (156, 232, 233).

High-resolution structural

information about the T-pilus would establish whether the T-pili have a lumen and, if so,
whether it is of sufficient diameter to accommodate passage of secretion substrates.
I invested a large amount of time and effort attempting to purify the T-pilus for
structural analysis. Purification proved challenging mainly due to contamination by the
bacterial flagellum. I tested several purification protocols involving sequential density
gradient centrifugation, e.g. sucrose and cesium chloride, and differential precipitation using
excess magnesium chloride. These methods served to enrich the T-pilus, however,
contaminating flagella were still present. We sent a highly enriched pilus sample to Dr. Joe
Wall at Brookhaven National Labs for a mass per unit length measurement by scanning
transmission electron microscope (STEM); this value was essential for use of iterative
helical real-space reconstruction (IHRSR) software for generating a high resolution
structure from pilus images collected by transmission electron microscopy. Results of the
STEM analysis showed that the T-pilus filament appeared to vary in mass per unit length
measurements. This may be due to an alternating structural arrangement along the length
of the T-pilus, or to sample degradation or contamination with other fimbriae or flagella
I attempted to purify the T-pili from flagellar-minus mutant strains nt1reB (234) and
fliR (235). However, the flagellar-minus mutant strains elaborate only very low levels of Tpili (Fig. 7.2).

While exploring the underlying mechanism responsible for the apparent

coordinated synthesis flagella and T-pili is of interest, the use of flagellar mutants
complicates efforts to purify T-pili in sufficient amounts for image reconstructions. Future
studies should explore the possibility of using other ‘bald’ strains or attempting to construct
a tagged, functional VirB2 variant that could be used for pilus enrichment by affinity
chromatography followed by other chromatography steps, e.g., gel filtration, to
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Figure 7.2 Effects of flagella minus mutant on surface display of VirB2 and observed
T-pili
Upper panel: fliR mutant displays reduction in extracellular VirB2 release. Extracellular blot
(surface) assay of flagella minus strain, fliR and negative controls ΔvirB2 and ΔvirB5. WT:
wild type strain A348. Lower panel: Electron micrographs of T-pili. Isolated T pili from a
flagella minus strain fliR were stained with 1% Uranyl acetate. Samples were viewed using
a Joel 1200 microscope. Black bar represents 50nm. Electron micrographs pictures were
taken by Dr. Angel Paredes PhD from samples I prepared.
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the purification protocol. With a completely pure sample, images could be collected by
electron microscopy for IHRSR.
Another way to gain structural information about the T-pilus is to refine our knowledge
of the pilin subunit packing geometry with a combination of SCAM and disulfide crosslinking
studies with or without oxidative catalysts, e.g., copper phenanthroline or thiol-reactive
chemical crosslinkers (236, 237). To date, I characterized a total of 16 Cys-substituted
pilins. In addition to the studies reported earlier in this thesis, I assayed for the capacity of
Cys-substitutions to form disulfide crosslinks in isolated T-pili. My initial findings support the
idea that the hydrophobic residues in domain II of adjacent monomers form a packing
interface. Those in the hydrophilic domains do not appear to form close contacts with the
corresponding region of adjacent monomers. Those of hydrophobic domain IV also do not
appear to pack against one another, but as noted in Chapter 3, this domain possesses a
Gly zipper motif which could participate in packing of VirB2 monomers. Therefore, it is
necessary to introduce additional Cys substitution mutations in this domain for a more
complete analysis (Fig. 7 3). Ideally, all functional Cys-substituted pilins among the entire
set of 74 replacements of native residues in the mature pilin would be subjected to the
types of MPB labeling analyses I carried out thus far. Additionally, for the subunit-subunit
packing studies by oxidative or chemical crosslinking, it would be necessary to
combinatorially express pairs of Cys-substituted pilins. These studies would very accurately
identify residues in the assembled T-pilus that are surface-exposed, exposed in the
presumptive lumen, and buried in subunit – subunit interfaces.

Confirm the Dislocase Activity of VirB4 and Identify Regions Required for VirB2VirB4 Interaction and Dislocase Activity
Scanning

cysteine

accessibility,

immunoprecipitation,

and

osmotic

shock

experiments all provided evidence that VirB4 functions as a pilin dislocase (chapter 4).
Future studies should rigorously test this model by i) assaying for dislocase activity in vitro,
and ii) identifying regions of VirB2 and VirB4 required for dislocase activity. VirB4 dislocase
activity can be tested further by using an in vitro reconstitution assay. Membrane vesicle
fusion experiments have previously been used to demonstrate and characterize the E. coli
FtsH dislocase activity (186, 238). Akiyama and Ito (238) showed that fusion of membrane
vesicles carrying ATPase FtsH with vesicles containing an FtsH substrate resulted in
translocation and FtsH-mediated degradation of the substrate. We do not think VirB4
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Figure 7.3 Disulfide crosslinking of Cys-substituted VirB2 in the T-pilus
Immunoblots of isolated T-pili developed with anti-VirB2 antibodies showing migration of
native VirB2 and mutant proteins in A) reducing B) non-reducing Tricine SDSpolyacrylamide gels. Non-reducing conditions in the presence (+) or absence (-) of the
oxidative crosslinker Copper phenanthroline (Cu-P).
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functions as a protease, so the FtsH dislocase assay would need to be modified. Initial
efforts could involve isolating membrane fractions from A. tumefaciens strains producing
VirB2 alone or VirB4 alone and mixing them together in the presence of PEG to fuse the
membranes. To assay for pilin release, one could attempt to use differential centrifugation
to separate the membrane vesicles from the pilin. However, even when released the
hydrophobic pilin might associate with or even re-integrate into the membrane. It could be
possible to make use of cysteine labeling to define VirB4-mediated changes in the pilin
structural state. Following membrane fusion, addition of MPB might identify exposed Cys
residues that in the absence of VirB4 are buried from this thiol-reactive reagent.
VirB4-like ATPases have been found associated with all known T4SSs (15) and
display similar physical properties such as size and the presence of conserved NTP-binding
motifs. To examine whether dislocase activity is a common property of VirB4 homologs,
approaches similar to the ones I used in my studies could be used. Interestingly, the lipid
composition of the membrane appears to dramatically influence the functionality of several
bacterial virulence systems (239, 240).

A. tumefaciens mutants lacking the lipid

phosphatidylcholine were shown to be unable to cause the formation of tumors on plants
(239). Recently, the ATPase TrwB, a coupling protein from the R388 system and homolog
of VirD4, was successfully purified and reconstituted into liposome bilayers (241). This
ATPase was shown to only express specific NTP binding activity when in the presence of a
membrane environment. These studies indicate that care must be taken when using
reconstituted liposomes systems in order to maintain proper protein function.
Another line of study should focus on analyzing VirB2 and VirB4 mutants to define
regions required for interaction and putative dislocase activity. Our lab has a large number
of VirB4 truncation and substitution mutants and a growing collection of VirB2 mutants
available to test for potential loss of interaction as monitored by immunoprecipitation and
dislocation as monitored by osmotic shock. I predict that a region of VirB4 that spans the
inner membrane is required for pilin dislocation via a direct protein-protein interaction. As
shown in Chapter 4, I supplied evidence by MPB-labeling for the extramembranous
location of at least one VirB4 Cys residues.

Further MPB-labeling studies of VirB4 Cys-

modified proteins (lacking some or all of the existing Cys residues, or carrying other Cys
replacements in putative periplasmic domain(s) would further define the transmembrane
domain(s) and potentially localize the pilin interaction domain. Additional mutations in this
domain could be characterized for effects on the VirB4 - pilin interaction and on pilin
dislocation.
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Confirm the Role of the VirB10 AP/BD in T-Pilus Polymerization
Results from Chapter 5 and 6 showed that VirB10 has a large influence on the pilus
biogenesis pathway. Most interestingly, the TM domain, the antennae projection (AP), and
bridging domain (BD) all appear to selectively contribute to T-pilus formation. Future studies
should test a model that the VirB10 AP forms the pore through which VirB2 pilin subunits
exit and actively promotes the polymerization of the T-pilus through direct contact.
My data suggest that deletion of the VirB10 AP confers release of VirB2 as
monomers, aggregates or short polymers. Follow-up studies should analyze the oligomeric
state of pilin on the surface of these cells by electron microscopy to further define the
function of the AP in pilus polymerization. A complementary approach would be to
characterize the structural organization of pilin released by the ΔAP mutant by MPB
labeling, and compare the labeling profile with that of pilins produced in the functionally
wild-type strain. These studies would begin to test our hypothesis that the VirB10 AP
participates in polymerization of the pilin subunits, perhaps by a strand-exchange method.
Further tests of this hypothesis would assay for a VirB2 interaction with VirB10, in
particular,

the

AP/BD

region.

Such

an

interaction

could

be

detected

by

coimmunoprecipitation (Co-IP) studies in the absence and presence of a protein
crosslinker. If an interaction were observed, deletion constructs and point mutations would
be tested in parallel to see if the interaction were disrupted and also, whether or not the
interaction is dependent on the presence of other VirB proteins, e.g. other core
components, ATPases, etc. Due to the potentially transient nature of the VirB2-VirB10
interaction, disulfide crosslinking experiments pairing cysteine substitutions within VirB2
(see chapter 3) and cysteine substitutions within VirB10 (69) may be more effective at
trapping a VirB2-VirB10 interaction.
If the VirB10 AP region is found to interact with VirB2, future studies should focus on
defining the requirements for this interaction. The AP region could be expressed as a
tagged protein fragment and tested for potential interaction with VirB2 via Co-IP and
protein-pull down assays. This fragment could then be overexpressed in the presence of
native VirB10 and tested for negative dominance on T-pilus polymerization. Strains bearing
mutations that permit substrate transfer but block pilus production (Tra+, Pil- ‘uncoupling
mutations) could also be tested for a loss of VirB2-VirB10 interaction.
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Determine if Deletion of the AP Domain Changes the Extracellular Localization VirB2
and VirB5
The T-pilus form a long thin (~10nm) filament that probably extends from the cell
pole (104, 121). Immunogold labeling has shown that VirB5 primarily localizes to the tip of
the T-pilus, while VirB2 extends the entire length of the pilus (121). In future studies, it will
be important to determine if the AP contributes to the spatial positioning of the pilin or pilus
at the cell surface. This could be achieved by analyzing the extracellular distribution of
VirB2 and VirB5 at the cell surface of wild-type vs. AP mutant strains using a combination of
immunofluorescence microscopy (IFM) and immunogold labeling paired with electron
microscopy.
In previous studies, it was shown that each VirB protein is required for elaboration of
the T-pilus (104). However, I observed that deletion of virB1 reduces but does not
completely abolish accumulation of extracellular VirB2, as monitored by the colony blot
assay and T-pilus shear assay (Fig. 7.4). Interestingly, although in previous studies VirB5
routinely displayed the same requirements as VirB2 for surface display, I was not able to
detect VirB5 in a ΔvirB1 mutant with the colony blot assay. I also was able to detect VirB2
but not VirB5 on the cell surface of the ΔvirB1 mutant by immunoflourescence microscopy,
even though both VirB2 and VirB5 accumulated at abundant levels in these cells (Fig. 7.5).
These findings raise the intriguing possibility that VirB1, a lytic transglycosylase (242), may
participate in polymerization of the pilus. Since my studies highlighted the importance of
VirB10 for pilus assembly, in future studies it will be interesting to determine whether VirB1
coordinates with VirB10 for pilus production. It is conceivable that the ΔAP mutant also
selectively blocks surface localization of VirB5, or that the ΔvirB1 mutant also releases pilin
monomers to the extracellular milieu. I could envision a model in which VirB1 interacts with
VirB10 to promote delivery of the pilus-tip-associated VirB5 subunit to the VirB10 AP. This
reaction would be required as a nucleation event for VirB2 recruitment and polymerization
into the T-pilus. In the absence of VirB5-VirB10 AP complex formation, VirB2 pilin would
not nucleate properly but in certain mutant strains, e.g., channel gating mutants, could still
be released to the cell surface as monomers, aggregates or short polymers. In future
studies, it will be intriguing to define the requirements at the outer membrane involving
VirB1, VirB5, and the VirB10 AP for pilus polymerization.
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Figure 7.4 Effects of virB deletion mutations on surface display of VirB2 and VirB5
A) total cellular material subjected to gel electrophoresis and blot development with antiVirB2 or anti-VirB5 antibodies revealing total cellular levels of the protein (cellular); B)
colony immunoblots developed with anti-VirB2 or anti-VirB5 antibodies showing presence of
surface-exposed pilin protein (surface); C) extracellular shear fraction subjected to
ultracentrifugation, gel electrophoresis and immunoblot development with anti-VirB2 or antiVirB5 antibodies revealing presence of high-molecular-weight T pilus (shear).
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Figure 7.5 : Immunofluorsecence assays showing localization VirB2 and VirB5 in the
wild-type strain and nonpolar virB1, virB2, and virB5 deletion mutants
VirB2 and VirB5 localization as monitored by immunofluorescence (IFM). AS-induced cells
were examined by IFM for VirB2 or B5 localization with Alexa-488- goat anti-rabbit IgG
probed with anti-VirB2 and anti-VirB5 antibodies. Corresponding DIC images by Nomarski
microscopy shown below. VirB2 and VirB5 both display peripheral fluorescence in wild type
cells, while only VirB2 shows fluorescence in the absence of VirB1.
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Screen for Effectors From other T4SSs Using ‘Leaky’ Channel Mutant
The ‘leaky’ channel mutant identified during the screen by the Lois Banta’s lab presents a
unique tool for identifying new, unknown substrates from related T4SSs. The G272R
mutation could serve as the genetic context for the introduction of a DNA library containing
tagged, unknown substrates that, like FLAG-VirE2, could be monitored for release to the
cell surface using the colony blot assay. In the limited studies of substrate recognition
signals, there is evidence that substrates from phylogenitically diverse species carry similar
secretion motifs (15).

If so, the A. tumefaciens VirB/VirD4 system might be a useful

surrogate for identification of secretion substrates of T4SSs from bacterial species that are
not genetically manipulable. For many human pathogens genetic tools and manipulations
are not available. A simple translocation assay based on release of effectors to the A.
tumefaciens cell surface could prove very useful for identification and characterization of
T4SS effectors from medically-important pathogens
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Perspectives
This is an exciting time for Type IV secretion systems (T4SS), as major structural
breakthroughs are providing unprecedented detail about the architecture of these
extraordinarily complex machines. The structures of the pKM101 outer membrane core
complex provide excellent detail and allow our field the opportunity to rigorously test the
structure/function relationship of these complexes and individual domains. Future advances
in the field will need to continue to rely on a combination of in vivo biochemical analyses
and in vitro isolation and structural resolution of larger machine subassemblies in order to
answer difficult questions such as: i) Do T4SS assemble as one vs. two organelles, the
secretion channel and T-pilus? ii) What is the physical relationship between the secretion
channel and the T-pilus? iii) Does T-pilus polymerization initiate from the outer membrane
or inner membrane? iv) What is the mechanism of action of VirB4 in dislocating pilin from
the inner membrane, and v) What other steps in the biogenesis pathway direct the pilin to
its final destination in the secretion channel or T-pilus?
T4SSs are intimately involved with a number of human and plant pathogens. A major,
ongoing goal of T4SS research is to discover new ways of preventing these systems from
contributing to disease progression (17). Many efforts have focused on identifying new
effector proteins (243, 244), expanding vaccine development (245), and designing small
molecule inhibitors (246). Intriguingly, outer membrane-associated and surface-localized
components of T4SSs have been tested for their ability to induce an immunogenic
response. In Anaplasma, for example, both VirB10-like and VirB2-like proteins were shown
to induce an immune response (18, 245, 247). Determining the principal mechanisms
responsible for T4SS biogenesis, channel gating, and intercellular translocation or release
of these proteins to the cell surface or milieu is central to the development of prevention
and treatment strategies for T4SS-associated diseases.
In recent years, significant progress has been made in deciphering underlying
mechanisms and molecular architectures of paradigmatic T4SSs.

However, the

identification of new uncharacterized T4SSs through genomic sequencing and in vivo
screens for virulence factors continues to raise more questions about the broad biological
functions of these machines in environmental or clinical settings. Ultimately, structure –
function studies of many different T4SS’s will be necessary to suppress their action or
exploit them for novel therapeutic or biotechnological applications.
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